var title_f38_55_39792="Calculator: Polycythemia vera diagnostic criteria (Original PVSG diagnostic criteria)";
var content_f38_55_39792=[" <div id=\"topicText\">",
"  <div id=\"mc3k\">",
"   <form action=\"\" id=\"PolycythemiaVera_form\" name=\"PolycythemiaVera_form\" onsubmit=\"return false;\">",
"    <table cellpadding=\"4\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\" width=\"100%\">",
"     <tr>",
"      <td bgcolor=\"#eeeeee\" width=\"1%\">",
"       <br/>",
"      </td>",
"      <td align=\"left\" bgcolor=\"#eeeeee\">",
"       <span class=\"medCalcFontTitleBox\">",
"        Calculator: Polycythemia vera diagnostic criteria (Original PVSG diagnostic criteria)",
"       </span>",
"      </td>",
"     </tr>",
"    </table>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_main\">",
"     <div id=\"calc_input\">",
"      <center>",
"       <table cellpadding=\"3\" cellspacing=\"0\" summary=\"MedCalc 3000 Table\">",
"        <tr>",
"         <td align=\"left\">",
"          <br/>",
"         </td>",
"         <td colspan=\"2\">",
"          <span class=\"medCalcFontIOBold\">",
"           Diagnostic :",
"          </span>",
"          <span class=\"medCalcFontCCTab\">",
"           2 Group A and 1 Group B and 0 Group C",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\">",
"          <br/>",
"         </td>",
"         <td colspan=\"2\">",
"          <span class=\"medCalcFontIOBold\">",
"           Diagnostic :",
"          </span>",
"          <span class=\"medCalcFontCCTab\">",
"           2 Group A and 0 Group B and 2 Group C",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td colspan=\"3\">",
"          &nbsp;",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\" colspan=\"3\">",
"          <span class=\"medCalcFontIOBold\">",
"           Group A",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\">",
"          &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"         </td>",
"         <td align=\"right\" valign=\"top\">",
"          <input name=\"cc1\" onclick=\"PolycythemiaVera_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Elevated RBC mass",
"           <br/>",
"           &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Males: &gt;=36 mL/kg",
"           <br/>",
"           &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Females: &gt;=32 mL/kg",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\">",
"          &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"         </td>",
"         <td align=\"right\" valign=\"top\">",
"          <input name=\"cc2\" onclick=\"PolycythemiaVera_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Arterial O2 saturation &gt;=92%",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\" colspan=\"3\">",
"          <span class=\"medCalcFontIOBold\">",
"           Group B",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\">",
"          &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"         </td>",
"         <td align=\"right\" valign=\"top\">",
"          <input name=\"cc3\" onclick=\"PolycythemiaVera_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Splenomegaly",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\" colspan=\"3\">",
"          <span class=\"medCalcFontIOBold\">",
"           Group C",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\">",
"          &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"         </td>",
"         <td align=\"right\" valign=\"top\">",
"          <input name=\"cc4\" onclick=\"PolycythemiaVera_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Platelet count &gt;400,000/microL",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\">",
"          &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"         </td>",
"         <td align=\"right\" valign=\"top\">",
"          <input name=\"cc5\" onclick=\"PolycythemiaVera_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           WBC count &gt;12,000/microL in the absence of fever or infection",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\">",
"          &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"         </td>",
"         <td align=\"right\" valign=\"top\">",
"          <input name=\"cc6\" onclick=\"PolycythemiaVera_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           Leukocyte alkaline phosphatase (LAP) score &gt;100 in the absence of fever or infection",
"          </span>",
"         </td>",
"        </tr>",
"        <tr>",
"         <td align=\"left\">",
"          &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;",
"         </td>",
"         <td align=\"right\" valign=\"top\">",
"          <input name=\"cc7\" onclick=\"PolycythemiaVera_fx();\" type=\"checkbox\"/>",
"         </td>",
"         <td align=\"left\">",
"          <span class=\"medCalcFontCCTab\">",
"           B12 &gt;900 pg/mL or serum unbound B12-binding capacity &gt;2200 pg/mL",
"          </span>",
"         </td>",
"        </tr>",
"       </table>",
"      </center>",
"     </div>",
"     <br/>",
"     &nbsp;",
"     <br/>",
"     <div id=\"calc_result\">",
"      <center>",
"       <textarea class=\"medCalcFontTextArea\" cols=\"35\" name=\"mccriteria\" onfocus=\"blur();\" rows=\"5\">",
"       </textarea>",
"      </center>",
"      <br/>",
"      &nbsp;",
"      <br/>",
"      <center>",
"       <input name=\"reset\" type=\"reset\" value=\"Reset Form\"/>",
"      </center>",
"     </div>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_notes\">",
"     <span class=\"medCalcFontOneBold\">",
"      Notes",
"     </span>",
"     <ul class=\"medCalcFontOne\">",
"      <li>",
"       <b>",
"        PVSG",
"       </b>",
"       is Polycythemia Vera Study Group",
"      </li>",
"     </ul>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_hints\">",
"     <span class=\"medCalcFontOne\">",
"     </span>",
"    </div>",
"    <br/>",
"    &nbsp;",
"    <br/>",
"    <div id=\"calc_refs\">",
"     <span class=\"medCalcFontRef\">",
"      <b>",
"       References",
"      </b>",
"     </span>",
"     <ol>",
"      <li>",
"       <span class=\"medCalcFontRef\">",
"        Berk PD, Goldberg JD, Donovan PB, et. al. Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.",
"        <i>",
"         Semin Hematol",
"        </i>",
"        . 1986 Apr;23(2):132-43.",
"       </span>",
"      </li>",
"     </ol>",
"    </div>",
"   </form>",
"   <script language=\"JavaScript1.1\" type=\"text/javascript\">",
"    &lt;!--",
"",
"",
"//--&gt;",
"   </script>",
"  </div>",
" </div>",
" <div id=\"topicAgreement\">",
"  Use of UpToDate is subject to the",
"  <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"   Subscription and License Agreement",
"  </a>",
"  .",
" </div>",
" <div id=\"printDisclaimer\">",
"  Information on this page may not appear correctly if printed.",
" </div>",
" <div id=\"disclaimerCalculator\">",
"  <div class=\"medCalcFontTwo\">",
"   <p class=\"header\">",
"    Legal Notices and Disclaimer",
"   </p>",
"   <p>",
"    All information contained in and produced by the MedCalc 3000 system is provided",
"			for educational purposes only. This information should not be used for the diagnosis or treatment",
"			of any health problem or disease.",
"    <b>",
"     THIS INFORMATION IS NOT INTENDED TO REPLACE CLINICAL JUDGMENT OR",
"			GUIDE INDIVIDUAL PATIENT CARE IN ANY MANNER.",
"    </b>",
"    <a class=\"medCalcDisclaimerLink\" href=\"./med-calc-disclaimer\">",
"     Click here for",
"				full notice and disclaimer.",
"    </a>",
"   </p>",
"   <p class=\"copy\">",
"    MedCalc 3000 is Copyright &copy; 1998-2013 Foundation Internet Services",
"   </p>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39792=[" ",
"",
"var calctxt = '';",
"var xmltxt = '';",
"var htmtxt = '';",
"",
"",
"",
"function PolycythemiaVera_fx() {",
"",
"with(document.PolycythemiaVera_form){",
"",
"mcResult = \"Insufficient\";",
"",
"setScore0 = 0;",
"setScore1 = 0;",
"setScore2 = 0;",
"",
"if (cc1.checked){ setScore0 = setScore0 + 1;",
"}",
"if (cc2.checked){ setScore0 = setScore0 + 1;",
"}",
"if (cc3.checked){ setScore1 = setScore1 + 1;",
"}",
"if (cc4.checked){ setScore2 = setScore2 + 1;",
"}",
"if (cc5.checked){ setScore2 = setScore2 + 1;",
"}",
"if (cc6.checked){ setScore2 = setScore2 + 1;",
"}",
"if (cc7.checked){ setScore2 = setScore2 + 1;",
"}",
"if (setScore0 >= 2 && setScore1 >= 1 && setScore2 >= 0) mcResult = \"Diagnostic\";",
"if (setScore0 >= 2 && setScore1 >= 0 && setScore2 >= 2) mcResult = \"Diagnostic\";",
"mccriteria.value = mcResult + ' with:\r\\n' + setScore0 + \" Group A \r\\n\" + setScore1 + \" Group B \r\\n\" + setScore2 + \" Group C \r\\n\";",
"",
"",
"}",
"",
"}",
""].join("\n");
var outline_f38_55_39792=null;
var title_f38_55_39793="Bullous arthropod bite";
var content_f38_55_39793=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F60230&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F60230&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Bullous arthropod (insect) bite",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A bulla is present in the site of an insect bite.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from:",
"     <a href=\"file://www.visualdx.com\" target=\"_blank\">",
"      www.visualdx.com",
"     </a>",
"     . Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39793=[""].join("\n");
var outline_f38_55_39793=null;
var title_f38_55_39794="Membranous VSD subcostal parasagittal 2D";
var content_f38_55_39794=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1176px;\">",
"  <div class=\"videoplayer\" h264=\"./images/CARD/58494/Membr_VSD_parasagit_movie.mp4?title=Membranous+VSD+subcostal+parasagittal+2D\" style=\"width:496px;height:384px\">",
"  </div>",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Membranous VSD subcostal parasagittal 2D",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 363px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In this subcostal parsagittal movie clip demonstrating a membranous ventricular septal defect, the movement and proximity of the aortic and tricuspid valves can be seen.",
"    <div class=\"footnotes\">",
"     PA: pulmonary artery; AO: aorta; LA: left atrium; RV: right ventricle; TV: tricuspid valve; RA: right atrium; IVC: inferior vena cava; arrow: VSD.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39794=[""].join("\n");
var outline_f38_55_39794=null;
var title_f38_55_39795="Talc (sterile): Patient drug information";
var content_f38_55_39795=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Talc (sterile): Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?27/39/28274?source=see_link\">",
"     see \"Talc (sterile): Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F6021564\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Sclerosol&reg;;",
"     </li>",
"     <li>",
"      Sterile Talc Powder&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10012418\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691449",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop fluid buildup in the lung cavity.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10012417\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to talc or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10012422\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10012423\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698189",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Irritation where the shot is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698081",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Fever.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698227",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Harm to the lungs may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10012425\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10012420\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696028",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given into the lung cavity.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10012427\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Read the package insert for more details.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12130 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-58.240.98.179-8913731101-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39795=[""].join("\n");
var outline_f38_55_39795=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6021564\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012418\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012417\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012422\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012423\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012425\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012420\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012427\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?27/39/28274?source=related_link\">",
"      Talc (sterile): Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_55_39796="Bipolar disorder (manic depression)";
var content_f38_55_39796=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Bipolar disorder (manic depression) (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?38/55/39796/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/55/39796/contributors\" id=\"au5683\">",
"       Jeffrey Stovall, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?38/55/39796/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/55/39796/contributors\" id=\"se7050\">",
"       Thomas L Schwenk, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?38/55/39796/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/55/39796/contributors\" id=\"de3194\">",
"       David Solomon, MD",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?38/55/39796?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Bipolar disorder, also known as manic depression, is a mental health problem that causes changes in mood. Sometimes you may feel excessively elated, impulsive, irritable, or irrational (called mania) or hypomanic (a milder form of mania). Other times you may feel excessively sad (called major depression).",
"    </p>",
"    <p>",
"     Bipolar disorder can make it hard to do a good job at work or school, have relationships with friends and family, and it even increases the risk of suicide if it is not treated or treated incorrectly. However, a number of effective treatment options are available.",
"    </p>",
"    <p>",
"     More detailed information about bipolar disorder is available by subscription. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/11/19639?source=see_link\">",
"      \"Bipolar disorder in adults: Epidemiology and diagnosis\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/8/38026?source=see_link\">",
"      \"Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/9/27802?source=see_link\">",
"      \"Bipolar disorder in adults: Maintenance treatment\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/3/43065?source=see_link\">",
"      \"Bipolar disorder in adults and lithium: Pharmacology, administration, and side effects\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      BIPOLAR DISORDER CAUSES",
"     </span>",
"    </p>",
"    <p>",
"     The exact cause of bipolar disorder is not clear. The problem may be related to an imbalance of chemicals in the brain. These chemicals allow cells to communicate with each other and play an essential role in all brain functions, including movement, sensation, memory, and emotions.",
"    </p>",
"    <p>",
"     Approximately one percent of people have bipolar disorder. People with a family history of bipolar disorder are at increased risk of developing the condition. Most people develop the first symptoms of bipolar disorder between age 15 to 30 years; it is uncommon to develop the first symptoms of bipolar as a child or as an adult over the age of 65.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H3\">",
"     <span class=\"h1\">",
"      BIPOLAR DISORDER SYMPTOMS",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Mania",
"     </span>",
"     &nbsp;&mdash;&nbsp;Mania causes you to feel abnormally and persistently happy, angry, hyperactive, impulsive, and irrational at different times. These feelings last at least one week, and may be severe enough that you need to be treated in a hospital. Other symptoms may include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Feelings of special powers and superiority",
"      </li>",
"      <li>",
"       Decreased need for sleep, restlessness",
"      </li>",
"      <li>",
"       Talking excessively",
"      </li>",
"      <li>",
"       Increased activity",
"      </li>",
"      <li>",
"       Racing thoughts",
"      </li>",
"      <li>",
"       Short attention span",
"      </li>",
"      <li>",
"       Inappropriate laughing or joking, or getting into lots of arguments",
"      </li>",
"      <li>",
"       Inappropriate spending sprees or sexual activity",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     Mania often causes difficulty maintaining relationships with friends and family, and can interfere with work or other responsibilities. During a manic episode, your moods can change rapidly from euphoria to depression or irritability.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Hypomania",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hypomania is less severe than mania, but it causes a change in mood that is abnormal. Hypomania is usually briefer than manic episodes, although it lasts for at least four days. Hypomania may not seriously affect your ability to work or go to school, and some people actually function better during a hypomanic episode. Hypomania may not need to be treated in a hospital, but it should be treated with medicines because it may lead to a manic or depressive episode.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H6\">",
"     <span class=\"h2\">",
"      Depression",
"     </span>",
"     &nbsp;&mdash;&nbsp;People with depression feel very sad and have trouble doing ordinary things like bathing, getting dressed, and cooking. You may feel sad most of the day or you may have little or no interest in any activity. Other symptoms may include:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Weight loss or gain (due to changes in how much you eat)",
"      </li>",
"      <li>",
"       Difficulty falling or staying asleep, or sleeping too much",
"      </li>",
"      <li>",
"       Feeling irritated easily",
"      </li>",
"      <li>",
"       Fatigue, loss of energy, sluggishness",
"      </li>",
"      <li>",
"       Feelings of worthlessness or guilt",
"      </li>",
"      <li>",
"       Difficulty concentrating and making decisions",
"      </li>",
"      <li>",
"       Recurring thoughts of death or suicide",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?19/41/20116?source=see_link\">",
"      \"Patient information: Depression in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H7\">",
"     <span class=\"h3\">",
"      Alcohol and drugs",
"     </span>",
"     &nbsp;&mdash;&nbsp;More than 60 percent of people with bipolar disorder abuse alcohol or drugs.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h3\">",
"      Suicide",
"     </span>",
"     &nbsp;&mdash;&nbsp;The risk of suicide also is higher in people with bipolar disorder compared to people with other psychiatric illnesses (including depression). Suicide is often the result of feeling hopeless, and is more likely in people with severe symptoms who must be hospitalized for treatment. If a family member or friend mentions suicide, you should consider this a serious threat and immediately contact the person's doctor or nurse. If you are having thoughts of suicide, call your doctor or nurse or go to the nearest emergency department.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H9\">",
"     <span class=\"h1\">",
"      BIPOLAR DISORDER DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     There is no test that can diagnose bipolar disorder. Instead, the diagnosis is based upon a medical and psychiatric history and a physical and mental status examination. Laboratory testing may be performed to rule out other diagnoses.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H10\">",
"     <span class=\"h1\">",
"      TREATMENT OF MANIA IN BIPOLAR DISORDER",
"     </span>",
"    </p>",
"    <p>",
"     Treatment of mania focuses on managing symptoms and keeping you safe. In the early phase of mania (called the acute phase), you may be psychotic (having false, fixed beliefs or hearing voices or seeing things others cannot see or hear). You may not be able to make good decisions and you may be at risk of hurting yourself or others. You may need to be treated in a hospital temporarily, until your medicine begins to work.",
"    </p>",
"    <p>",
"     Medicines are the main treatment for mania, and a number of medicines are available. It is not usually possible to know ahead of time which medicine will be the most effective and cause the fewest side effects. It may be necessary to try several medicines before finding the best one.",
"    </p>",
"    <p>",
"     Treatment of mania continues until your symptoms completely resolve and you are able to function. Many people continue to take medicine for a long time to prevent a recurrence of mania.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Mood stabilizers",
"     </span>",
"     &nbsp;&mdash;&nbsp;Medicines such as lithium, lamotrigine, valproate, and carbamazepine, are often used first in the treatment of mania or hypomania. All of these medicines may be effective, and the choice is often made based upon what medicines you have taken before, side effects, and any underlying medical illnesses.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H12\">",
"     <span class=\"h3\">",
"      Lithium",
"     </span>",
"     &nbsp;&mdash;&nbsp;Lithium has been used for many years to treat mania. Common side effects of lithium can include frequent urination, tremor, loose stools, difficulty thinking clearly, or weight gain. Problems with kidney function, heart rhythm, or thyroid functioning can occur in people who take lithium for long periods of time.",
"    </p>",
"    <p>",
"     A test to measure the lithium level in the blood is recommended regularly when taking lithium. Blood testing is usually done every 6 to 12 months once the lithium dose is stabilized.",
"    </p>",
"    <p>",
"     Lithium can cause serious problems if you take an overdose or if your kidneys do not work normally. This can occur if you becomes severely dehydrated or take certain medicines with lithium. If you take lithium, talk to your healthcare provider before taking any new non-prescription or prescription medicines.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h3\">",
"      Valproate",
"     </span>",
"     &nbsp;&mdash;&nbsp;Valproate is a medicine that is also effective in treating mania. It may be used instead of or in combination with lithium. Common side effects of valproate include weight gain, nausea, vomiting, hair loss, easy bruising, and tremor. Blood testing is usually done to check blood levels and to check for potential complications.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h3\">",
"      Carbamazepine",
"     </span>",
"     &nbsp;&mdash;&nbsp;Carbamazepine is also helpful in the treatment of bipolar disorder. The most common side effects of carbamazepine include nausea, vomiting, diarrhea, rash, itching, and fluid retention. Blood testing is recommended to check blood levels and to check for potential complications.",
"    </p>",
"    <p>",
"     Carbamazepine interferes with certain birth control methods (pill, vaginal ring, patch), making these methods less effective in preventing pregnancy (see",
"     <a class=\"local\" href=\"#H27\">",
"      'Birth control'",
"     </a>",
"     below).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Antipsychotic medicines",
"     </span>",
"     &nbsp;&mdash;&nbsp;Antipsychotic medicines may be used alone or in combination with a mood stabilizer to treat mania or depression.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Certain antipsychotic medicines, such as olanzapine (Zyprexa&reg;), risperidone (Risperdal&reg;), and quetiapine (Seroquel&reg;) have a risk of weight gain, high blood sugar, diabetes mellitus, and high cholesterol.",
"      </li>",
"      <li>",
"       The antipsychotic medicines ziprasidone (Geodon&reg;) and aripiprazole (Abilify&reg;) may work as well as other antipsychotic medicines, but with a lower risk of weight gain and diabetes.",
"      </li>",
"      <li>",
"       Clozapine (Clozaril&reg;) is an antipsychotic medicine that may be particularly effective in patients who do not respond to other mood stabilizers or antipsychotics, However, it carries a risk of lowering the white blood cell count to a dangerously low level. Blood testing is required once per week.",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h1\">",
"      TREATMENT OF DEPRESSION IN BIPOLAR DISORDER",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H17\">",
"     <span class=\"h2\">",
"      Mood stabilizers",
"     </span>",
"     &nbsp;&mdash;&nbsp;Mood stabilizers, such as lamotrigine and lithium, are commonly used to treat depression in people with bipolar disorder. Lithium is discussed above (see",
"     <a class=\"local\" href=\"#H12\">",
"      'Lithium'",
"     </a>",
"     above).",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H18\">",
"     <span class=\"h3\">",
"      Lamotrigine",
"     </span>",
"     &nbsp;&mdash;&nbsp;Lamotrigine was developed to treat seizures, but it is also effective for people with bipolar depression. Routine blood tests are not needed for monitoring.",
"    </p>",
"    <p>",
"     Lamotrigine can have serious side effects when taken with other medicines; be sure that your healthcare provider has an updated list of your prescription and nonprescription medicines. An infrequent but serious rash (called Stevens-Johnson syndrome) can occur early in treatment; call your healthcare provider if you notice a new rash while taking lamotrigine.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H19\">",
"     <span class=\"h2\">",
"      Antipsychotics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Antipsychotic medicines may help to treat bipolar depression (see",
"     <a class=\"local\" href=\"#H15\">",
"      'Antipsychotic medicines'",
"     </a>",
"     above). In particular, olanzapine or quetiapine can be helpful for patients with bipolar depression. &nbsp;In some cases, an antipsychotic medicine is combined with an antidepressant medicine.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H20\">",
"     <span class=\"h2\">",
"      Antidepressants",
"     </span>",
"     &nbsp;&mdash;&nbsp;Antidepressants are sometimes used to treat people with bipolar depression, sometimes in combination with a mood stabilizer. However, people with bipolar disorder who use antidepressants must be monitored closely because there is a chance that antidepressants can cause a manic episode.",
"    </p>",
"    <p>",
"     There are several types of antidepressants, each of which works differently.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Selective serotonin reuptake inhibitors (eg, fluoxetine (Prozac&reg;), fluvoxamine (Luvox&reg;), sertraline (Zoloft&reg;), paroxetine (Paxil&reg;), citalopram (Celexa&reg;), and escitalopram (Lexapro&reg;)) (see",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?5/28/5578?source=see_link\">",
"        \"Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects\"",
"       </a>",
"       ).",
"      </li>",
"      <li>",
"       Venlafaxine (Effexor&reg;) and duloxetine (Cymbalta&reg;) (see",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?5/28/5578?source=see_link\">",
"        \"Serotonin-norepinephrine reuptake inhibitors (SNRIs): Pharmacology, administration, and side effects\"",
"       </a>",
"       ).",
"      </li>",
"      <li>",
"       Mirtazapine (Remeron&reg;) (see",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7574?source=see_link\">",
"        \"Monoamine oxidase inhibitors (MAOIs) for treating depressed adults\"",
"       </a>",
"       ).",
"      </li>",
"      <li>",
"       Bupropion (Wellbutrin&reg;) (see",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7574?source=see_link\">",
"        \"Monoamine oxidase inhibitors (MAOIs) for treating depressed adults\"",
"       </a>",
"       ).",
"      </li>",
"      <li>",
"       Monoamine oxidase inhibitors (tranylcypromine (Parnate&reg;) and phenelzine (Nardil&reg;)) (see",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?7/25/7574?source=see_link\">",
"        \"Monoamine oxidase inhibitors (MAOIs) for treating depressed adults\"",
"       </a>",
"       ).",
"      </li>",
"      <li>",
"       Tricyclic antidepressants (see",
"       <a class=\"medical medical_review\" href=\"mobipreview.htm?35/20/36169?source=see_link\">",
"        \"Unipolar depression in adults and tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects\"",
"       </a>",
"       ).",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H21\">",
"     <span class=\"h2\">",
"      Electroconvulsive therapy (ECT)",
"     </span>",
"     &nbsp;&mdash;&nbsp;During electroconvulsive therapy (ECT), an electrical current is passed through the brain, triggering a seizure. Patients typically receive 6 to 12 such treatments, with at least one day in between each treatment. For unknown reasons, these seizures help to restore the normal balance of chemicals in the brain. ECT is especially effective for people with severe, life-threatening depression that has not responded to medicines. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?36/50/37664?source=see_link\">",
"      \"Patient information: Electroconvulsive therapy (ECT) (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     ECT can be used in pregnant women and in those who cannot tolerate antidepressant or mood stabilizing medicines, and is especially useful for those who need a treatment that begins working rapidly. Although ECT has been negatively portrayed as \"shock therapy\" in the media, this therapy often provides rapid and dramatic relief of symptoms and has few side effects.",
"    </p>",
"    <p>",
"     Patients who undergo ECT are given anesthesia to induce sleep and prevent pain. The person's heart and breathing rate, oxygen levels, and blood pressure are carefully monitored before, during, and after treatment is given. Side effects of this therapy include confusion and memory loss.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H22\">",
"     <span class=\"h1\">",
"      BIPOLAR DISORDER MAINTENANCE THERAPY",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H23\">",
"     <span class=\"h2\">",
"      Medicines",
"     </span>",
"     &nbsp;&mdash;&nbsp;Once the worst symptoms of mania or depression are under control, treatment focuses on preventing a recurrence. People who have suffered a manic episode are often advised to continue taking medicine(s) to control bipolar disorder. This usually includes a single mood stabilizing medicine, such as lithium or valproate. Other medicines may also be recommended if, for example, a single mood stabilizer is not helpful or you cannot tolerate the side effects.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H24\">",
"     <span class=\"h2\">",
"      Psychotherapy (counseling)",
"     </span>",
"     &nbsp;&mdash;&nbsp;Although medicines are the treatment of choice for bipolar disorder, counseling and talk therapy also have an important role in treatment. This is especially true after an acute episode has passed.",
"    </p>",
"    <p>",
"     Psychotherapy may include individual counseling as well as education, marital and family therapy, or treatment of alcohol",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     drug abuse. Therapy can help you to stick with your medicine, which can decrease the risk of relapse and the need for hospitalization.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H25\">",
"     <span class=\"h1\">",
"      WOMEN AND BIPOLAR DISORDER",
"     </span>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H26\">",
"     <span class=\"h2\">",
"      Pregnancy",
"     </span>",
"     &nbsp;&mdash;&nbsp;Women who are taking medicines for bipolar disorder and considering pregnancy should talk with their doctor or nurse. If you take medicine for bipolar and discover you are pregnant, do not stop your medicine suddenly. Instead, speak with your healthcare provider to determine if you should continue your medicine, change to another medicine, or slowly taper the medicine.",
"    </p>",
"    <p>",
"     The decision to continue taking medicine during pregnancy is a hard one because of the potential risks to you (if you are not treated or undertreated), your developing baby, and your family. You should discuss all of the risks and benefits of treatment with a knowledgeable and experienced healthcare provider who can help to decide which treatment, if any, is best.",
"    </p>",
"    <p>",
"     During your discussion, consider the following issues:",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Infants of women who take lithium during the first trimester of pregnancy have an increased risk of heart malformations. However, the risk is very low. Women who require lithium are generally advised to remain on lithium. An ultrasound of the baby's heart is usually recommended at 18 to 20 weeks of pregnancy to screen for heart defects. There are no known long-term behavioral effects of lithium in children.",
"      </li>",
"      <li>",
"       Anticonvulsant medicines, including carbamazepine, lamotrigine, and valproate increase the risk of birth defects and are not usually recommended during pregnancy.",
"      </li>",
"      <li>",
"       If you continue to take valproate or carbamazepine, you should take a supplement containing 4 milligrams of folic acid starting 3 months before trying to become pregnant and continuing for 3 months after becoming pregnant. This may reduce the risk of a type of birth defect, known as neural tube defects, which may be more common in infants of mothers who take valproate or carbamazepine.",
"      </li>",
"      <li>",
"       Newer antipsychotic medicines, including olanzapine and quetiapine are not known to cause birth defects, but there is not as much information about the safety of these medicines during pregnancy. In addition, there are no long-term data about how these medicines could potentially affect the child.",
"      </li>",
"      <li>",
"       The potential risks of antidepressant medicines are discussed in a separate article. (See",
"       <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/24/21894?source=see_link&amp;anchor=H25#H25\">",
"        \"Patient information: Depression treatment options for adults (Beyond the Basics)\", section on 'Antidepressants and pregnancy'",
"       </a>",
"       .)",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H27\">",
"     <span class=\"h2\">",
"      Birth control",
"     </span>",
"     &nbsp;&mdash;&nbsp;Some of the medicines used to treat bipolar disorder, including carbamazepine, interact with birth control pills, skin patch, and vaginal ring. As a result, women who take these medicines should consider another method of birth control (eg, an injection of depo-medroxyprogesterone acetate, condoms, or an intrauterine device). (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/60/9157?source=see_link\">",
"      \"Patient information: Birth control; which method is right for me? (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     The blood level of one medicine, lamotrigine, is decreased in women who take birth control pills. Some women who take lamotrigine and a birth control pill will need a higher dose of lamotrigine.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H28\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H281\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14512961\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?4/5/4178?source=see_link\">",
"      Patient information: Bipolar disorder (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?36/15/37106?source=see_link\">",
"      Patient information: Electroconvulsive therapy (ECT) (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14512978\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?19/41/20116?source=see_link\">",
"      Patient information: Depression in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?21/24/21894?source=see_link\">",
"      Patient information: Depression treatment options for adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/60/9157?source=see_link\">",
"      Patient information: Birth control; which method is right for me? (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H30\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/63/32761?source=see_link\">",
"      Adult attention deficit hyperactivity disorder",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/11/19639?source=see_link\">",
"      Bipolar disorder in adults: Epidemiology and diagnosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/9/27802?source=see_link\">",
"      Bipolar disorder in adults: Maintenance treatment",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/8/38026?source=see_link\">",
"      Bipolar disorder in adults: Pharmacotherapy for acute mania, mixed episodes, and hypomania",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/10/39081?source=see_link\">",
"      Diagnosis of delirium and confusional states",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/24/7562?source=see_link\">",
"      First-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?4/31/4600?source=see_link\">",
"      First generation (Typical) antipsychotic medication poisoning",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/58/28583?source=see_link\">",
"      Overview of psychosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/39/17014?source=see_link\">",
"      Postpartum psychosis: Epidemiology, clinical manifestations, and assessment",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/62/29670?source=see_link\">",
"      Treatment of postpartum psychosis",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/25/22936?source=see_link\">",
"      Seasonal affective disorder",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/10/15530?source=see_link\">",
"      Second-generation antipsychotic medications: Pharmacology, administration, and comparative side effects",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/19/43320?source=see_link\">",
"      Second generation (atypical) antipsychotic medication poisoning",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/20/36169?source=see_link\">",
"      Unipolar depression in adults and tricyclic and tetracyclic drugs: Pharmacology, administration, and side effects",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/healthtopics.html\">",
"      www.nlm.nih.gov/medlineplus/healthtopics.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Mental Health",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nimh.nih.gov/health/publications/bipolar-disorder/complete-index.shtml\">",
"      www.nimh.nih.gov/health/publications/bipolar-disorder/complete-index.shtml",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       Depression and Bipolar Support Alliance (DBSA)",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.dbsalliance.org/\">",
"      www.DBSAlliance.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Mental Health Association",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nmha.org/\">",
"      www.nmha.org",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Alliance for the Mentally Ill",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nami.org/\">",
"      www.nami.org/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?38/55/39796/abstract/1-5\">",
"      1-5",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 26, 2012.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?38/55/39796?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39796/abstract/1\">",
"      Keck PE Jr, McElroy SL. Outcome in the pharmacologic treatment of bipolar disorder. J Clin Psychopharmacol 1996; 16:15S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39796/abstract/2\">",
"      Keck PE Jr, McElroy SL, Arnold LM. Bipolar disorder. Med Clin North Am 2001; 85:645.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39796/abstract/3\">",
"      Gijsman HJ, Geddes JR, Rendell JM, et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004; 161:1537.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39796/abstract/4\">",
"      American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002; 159:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39796/abstract/5\">",
"      M&uuml;ller-Oerlinghausen B, Bergh&ouml;fer A, Bauer M. Bipolar disorder. Lancet 2002; 359:241.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f38_55_39796=[""].join("\n");
var outline_f38_55_39796=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           BIPOLAR DISORDER CAUSES",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H3\">",
"           BIPOLAR DISORDER SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H9\">",
"           BIPOLAR DISORDER DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H10\">",
"           TREATMENT OF MANIA IN BIPOLAR DISORDER",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H16\">",
"           TREATMENT OF DEPRESSION IN BIPOLAR DISORDER",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H22\">",
"           BIPOLAR DISORDER MAINTENANCE THERAPY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H25\">",
"           WOMEN AND BIPOLAR DISORDER",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H28\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f38_55_39797="Mediastinal seminoma II Low";
var content_f38_55_39797=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F54661&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F54661&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Cystic mediastinal seminoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 246px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power photomicrograph shows a multilocular thymic cyst containing tumor cells of seminoma in the cystic wall. (Hematoxylin and eosin, magnification 10x).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of William Travis, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39797=[""].join("\n");
var outline_f38_55_39797=null;
var title_f38_55_39798="Chlamydia reticulate bodies";
var content_f38_55_39798=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F79945&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F79945&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Reticulate bodies of chlamydial infection",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 360px; height: 269px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph of an infected epithelial cell containing multiple reticulate bodies, the replicating form of Chlamydia trachomatis.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from the Centers for Disease Control and Prevention.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39798=[""].join("\n");
var outline_f38_55_39798=null;
var title_f38_55_39799="Tools for genetics and genomics: Gene expression";
var content_f38_55_39799=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Tools for genetics and genomics: Gene expression",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/55/39799/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/55/39799/contributors\">",
"     Avrum Spira, MD, MSc",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/55/39799/contributors\">",
"     Katrina Steiling, MD, MSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/55/39799/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/55/39799/contributors\">",
"     Benjamin A Raby, MD, MPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/55/39799/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/55/39799/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/55/39799/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 26, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H3544017\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The genetic basis for disease is determined by the inheritance of genes containing specific sequences of DNA. The phenotypic expression of these genes, through the synthesis of specific proteins, involves interaction with environmental signals that trigger activation of particular genes.",
"   </p>",
"   <p>",
"    According to the central dogma of biology, RNA is transcribed from a DNA template; messenger RNA (mRNA) is then translated into protein (",
"    <a class=\"graphic graphic_figure graphicRef54914 \" href=\"mobipreview.htm?39/61/40926\">",
"     figure 1",
"    </a>",
"    ). Transcription and translation underlie gene expression.",
"   </p>",
"   <p>",
"    Approximately 3 to 5 percent of genes are active in a particular cell, even though all cells have the same information contained in their DNA. Most of the genome is selectively repressed, a property that is governed by the regulation of gene expression, mostly at the level of transcription (ie, the production of messenger RNA from the DNA). In response to a cellular perturbation, changes in gene expression take place that result in the expression of hundreds of gene products and the suppression of others. This molecular heterogeneity can affect when and how a disease presents clinically in an individual with genetic predisposition to a condition and how individuals with a given disease will respond to specific treatments.",
"   </p>",
"   <p>",
"    Analyses of gene expression can be clinically useful for disease classification, diagnosis, prognosis, and tailoring treatment to underlying genetic determinants of pharmacologic response.",
"   </p>",
"   <p>",
"    This topic will focus on the role of mRNA in the cell, platforms for profiling mRNA expression, the challenges in interpreting the data from these analyses, and the emerging clinical applications of gene expression measurements. An overview of molecular genetics and the role of gene expression profiling in clinical oncology are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/27/17846?source=see_link\">",
"     \"Principles of molecular genetics\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/47/39674?source=see_link\">",
"     \"Overview of gene expression profiling, proteomics, and microRNA profiling in clinical oncology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95557489\">",
"    <span class=\"h1\">",
"     RNA IN CELL FUNCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several classes of RNA. Messenger RNA (mRNA) is the RNA that is translated into protein. Noncoding RNAs are not translated into protein and serve other functions in the cell. Classes of noncoding RNAs include transfer RNAs (tRNAs), ribosomal RNAs (rRNAs), small nuclear RNAs (snRNAs), small nucleolar RNAs (snoRNAs), microRNAs, Piwi-interacting RNAs (piRNAs), and large intergenic noncoding RNAs (lincRNAs) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/1-5\">",
"     1-5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Messenger RNA accounts for about 1 percent of the total RNA in a cell [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/6\">",
"     6",
"    </a>",
"    ] and is transcribed from approximately 20,000 to 25,000 protein-coding genes in the human genome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/7\">",
"     7",
"    </a>",
"    ]. After mRNA is transcribed from DNA, it typically undergoes further modifications including the addition of a methyl-guanosine cap (5' cap), the addition of a series of adenines to the 3' end of RNA (poly-A tail), and the splicing out of introns (",
"    <a class=\"graphic graphic_figure graphicRef70605 \" href=\"mobipreview.htm?21/43/22193\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/1\">",
"     1",
"    </a>",
"    ]. mRNA is then transported from the nucleus to the cytoplasm where it is translated into protein. Messenger RNA serves as a transient intermediate between DNA and protein, and is degraded in minutes to hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544024\">",
"    <span class=\"h1\">",
"     MEASURING GENE EXPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Since mRNA represents the functional bridge between DNA and protein, alterations in mRNA may serve as markers for the activation or inhibition of a particular gene.",
"   </p>",
"   <p>",
"    The challenge in measuring RNA relates to the susceptibility of RNAs to degradation by ribonucleases (RNases). Methods of RNA detection take advantage of the single stranded structure of RNA and its complementarity to the DNA from which it was transcribed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544040\">",
"    <span class=\"h2\">",
"     Early approaches",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to the development of microarray technology, available methods of measuring gene expression included:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Northern blot",
"     </li>",
"     <li>",
"      Ribonuclease protection assay",
"     </li>",
"     <li>",
"      In-situ hybridization",
"     </li>",
"     <li>",
"      Spotted cDNA arrays",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A comparison of these methods is summarized in a table (",
"    <a class=\"graphic graphic_table graphicRef76106 \" href=\"mobipreview.htm?26/61/27613\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544047\">",
"    <span class=\"h3\">",
"     Northern blot",
"    </span>",
"    &nbsp;&mdash;&nbsp;Northern blots allow the determination of both the presence of an RNA molecule and its size [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/8\">",
"     8",
"    </a>",
"    ]. RNA molecules are first separated based on size using gel electrophoresis. The size-separated RNA molecules are then transferred and cross-linked to a nylon membrane. The RNA of interest is detected by incubating the membrane with a labeled single-stranded DNA probe that is complimentary to this RNA. Probe bound to the RNA of interest can then be detected using autoradiography or chemiluminescence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544054\">",
"    <span class=\"h3\">",
"     Ribonuclease protection assay",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whereas the Northern blot uses complimentary DNA probes, the ribonuclease protection assay (RPA) uses antisense RNA probes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/6\">",
"     6",
"    </a>",
"    ]. These so-called riboprobes are single-stranded radiolabeled RNA molecules complimentary to the RNA of interest. The riboprobe is incubated with the RNA from the sample and binds to complementary RNA to form double-stranded RNA complexes. Incubating the mixture with ribonucleases degrades unbound single-stranded RNA from both the sample and excess probe. The remaining double stranded RNA complexes are size-separated by electrophoresis, and detected by autoradiography.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544061\">",
"    <span class=\"h3\">",
"     In-situ hybridization",
"    </span>",
"    &nbsp;&mdash;&nbsp;In-situ hybridization (ISH) uses a nucleic acid probe to detect any other nucleic acids in a tissue section. ISH can localize the RNA of interest at the anatomic or cellular level. The tissue section is fixed to preserve tissue morphology and nucleic acid integrity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. The sample is then treated with proteases to eliminate proteins bound to the RNA of interest [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/9,10\">",
"     9,10",
"    </a>",
"    ]. A labeled probe is hybridized to the sample and detected using autoradiography or chemiluminescence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/10\">",
"     10",
"    </a>",
"    ]. In-situ hybridization using a chemiluminescence-labeled probe is also called fluorescent in situ hybridization (FISH). &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544068\">",
"    <span class=\"h3\">",
"     Spotted cDNA arrays",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unlike Northern blot, RPA, or ISH, spotted cDNA arrays are capable of testing the relative expression levels, between two conditions, of several hundred genes. With increased knowledge of which sequences are expressed from the genome, it became possible to create cDNA probes targeting the expressed DNA sequences from which RNA is transcribed. &nbsp;",
"   </p>",
"   <p>",
"    cDNA probes are amplified using PCR and spotted onto a glass slide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/11\">",
"     11",
"    </a>",
"    ]. RNA is then isolated from two samples representing different conditions. mRNA from each sample is isolated, and labeled with one of two fluorescent dyes (green or red) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/12\">",
"     12",
"    </a>",
"    ]. The samples are then mixed together and co-hybridized to the cDNA probes on the glass slide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/11\">",
"     11",
"    </a>",
"    ]. This approach directly compares gene expression in the first condition to the second condition, and allows the detection of as many genes as there are probes on the array. However, reproducibility is limited across arrays because of the need to manually spot probes on slides.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544075\">",
"    <span class=\"h2\">",
"     Contemporary gene expression profiling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recent platforms for profiling gene expression take advantage of increased knowledge of the sequence of the human genome and require smaller quantities of starting RNA. Current platforms for profiling gene expression include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oligonucleotide arrays (microarrays)",
"     </li>",
"     <li>",
"      Reverse-transcription quantitative polymerase chain reaction (RT-PCR)",
"     </li>",
"     <li>",
"      Transcriptome sequencing",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A comparison of these methods is summarized in a table (",
"    <a class=\"graphic graphic_table graphicRef76106 \" href=\"mobipreview.htm?26/61/27613\">",
"     table 1",
"    </a>",
"    ) .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95557895\">",
"    <span class=\"h3\">",
"     Oligonucleotide arrays (microarrays)",
"    </span>",
"    &nbsp;&mdash;&nbsp;Oligonucleotide arrays operate on a similar principle to spotted cDNA arrays, but differ in how they are produced. Rather than spotting probes onto a glass slide, the short probes are synthesized directly on the slide [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/13,14\">",
"     13,14",
"    </a>",
"    ]. Depending on the commercial manufacturer, probes vary from ~20 to 60 base pairs in length. Several types of arrays are commercially available.",
"   </p>",
"   <p>",
"    Sample preparation begins with the isolation of RNA from the tissue of interest, resulting in an extraction that contains all of the genes transcribed in the tissue at the time the RNA is isolated. The RNA is then reverse-transcribed into cDNA and amplified using polymerase chain reaction (PCR) technique. Finally, a",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?9/25/9618?source=see_link\">",
"     biotin",
"    </a>",
"    label is incorporated through an in vitro transcription process, which converts cDNA into labeled cRNA.",
"   </p>",
"   <p>",
"    A single sample of the labeled cRNA is applied to each array. Hybridization occurs between the labeled cRNA from the sample and complementary probes on the array. This is followed by binding to an avidin-conjugated fluorophore, and a washing step that removes any unbound material. The fluorophore is excited by a laser scanner coupled to a computer that captures the image fluorophores linked to hybridized target molecules on the array, thus enabling the detection of the expression of thousands of genes simultaneously.",
"   </p>",
"   <p>",
"    In general, the greater the amount of mRNA from a particular gene (ie, the higher the expression of that gene), the more fluorescently-labeled material corresponding to that gene will bind to complementary probes on the array. Background fluorescence or nonspecific binding may limit detection of lowly expressed transcripts. Probe-based detection for gene expression limits analysis to genes that are known.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95557343\">",
"    <span class=\"h3\">",
"     Real-time reverse transcription polymerase chain reaction",
"    </span>",
"    &nbsp;&mdash;&nbsp;Real-time reverse transcription polymerase chain reaction (RT-PCR) is a relatively simple approach to assay large numbers of genes from a single sample [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/15\">",
"     15",
"    </a>",
"    ]. After isolating RNA from a sample, complementary DNAs (cDNAs) are synthesized by reverse transcription with an RNA-dependent DNA polymerase. This cDNA mixture is then combined with a DNA-dependent DNA polymerase and fluorescent-labeled oligonucleotide primers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/16\">",
"     16",
"    </a>",
"    ]. These primers are short sequences of nucleotides complementary to a portion of the cDNA and allow amplification. Fluorescence increases as the cDNA of interest is amplified with PCR. The fluorescent intensity is monitored and the total number of PCR cycles is counted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/6\">",
"     6",
"    </a>",
"    ]. The point at which the PCR cycler can distinguish fluorescence related to gene amplification from background is the cycle threshold, and can be used to estimate the relative starting quantity of the RNA of interest [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/15\">",
"     15",
"    </a>",
"    ]. Careful primer selection is required to prevent amplification of related genes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544096\">",
"    <span class=\"h3\">",
"     Transcriptome sequencing",
"    </span>",
"    &nbsp;&mdash;&nbsp;A newer alternative for measuring gene expression is the direct sequencing and quantification of RNA molecules. This method of measuring gene expression has also been referred to as &ldquo;RNA-seq&rdquo;, &ldquo;massively parallel sequencing&rdquo;, &ldquo;next generation sequencing&rdquo;, or &ldquo;deep sequencing&rdquo;, and several commercial platforms are available. The details of each system vary. In general, the sample is prepared so that many sequencing reactions occur simultaneously on a glass slide, and yields millions of RNA sequence reads obtained by laser scanning [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/17\">",
"     17",
"    </a>",
"    ]. This technique allows improved detection of low abundance transcripts, as well as detection of novel transcripts and polymorphisms within a transcript&rsquo;s sequence.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544103\">",
"    <span class=\"h2\">",
"     Microarray analysis and interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microarrays can assay large numbers of genes with relatively high throughput. They are currently the platform most often used for gene expression profiling of clinical specimens. Typically, investigators involved with microarray experiments are interested in comparing gene expression across different conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/18\">",
"     18",
"    </a>",
"    ]. While there are many approaches to the data analysis in order to accomplish this goal, there are generally several analytical steps that must first be taken (",
"    <a class=\"graphic graphic_figure graphicRef71360 \" href=\"mobipreview.htm?3/22/3424\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    There are four general considerations in approaching microarray data analysis and interpretation:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Normalization, quality assessment, and preprocessing",
"     </li>",
"     <li>",
"      Data storage and analysis",
"     </li>",
"     <li>",
"      Multiple comparison problem",
"     </li>",
"     <li>",
"      Biological interpretation",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544110\">",
"    <span class=\"h3\">",
"     Normalization, quality assessment, and preprocessing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Normalization adjusts measured fluorescent intensities so that they are comparable across different experiments. Quality assessment eliminates low-quality microarrays or measurements. Preprocessing prepares the data for statistical analysis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544117\">",
"    <span class=\"h4\">",
"     Normalization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each microarray can be considered a separate experiment that contains slightly different amounts of starting RNA and different labeling efficiencies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/18\">",
"     18",
"    </a>",
"    ]. Data normalization adjusts the fluorescent intensities representing the amount of RNA bound to each probe so that these intensities are comparable across different arrays. There are several methods for normalizing microarray data, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Scaling &mdash; Adjusts intensities by a constant factor so that the average expression level across microarrays is similar.",
"     </li>",
"     <li>",
"      Quantile normalization &mdash; Adjusts the distribution of intensities across microarrays. This is accomplished by ranking the probe intensities from highest to lowest for each array. A numerical value is assigned to represent this intensity on an individual array based on the behavior across all arrays and the rank of that probe on the individual array.",
"     </li>",
"     <li>",
"      Locally weighted scatterplot smoothing (LOWESS) &mdash; Adjusts the brightness or darkness of different fluorescent labels for two-color array experiments.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544124\">",
"    <span class=\"h4\">",
"     Quality assessment",
"    </span>",
"    &nbsp;&mdash;&nbsp;Quality assessment occurs both before and after data normalization.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Pre-normalization quality assessment evaluates the microarray itself to ensure there are no bubbles, scratches, or other artifacts on the array. Some commercial arrays also contain controls inserted during sample processing (&ldquo;spike-in&rdquo; controls) to ensure that all steps leading to the hybridization were successful.",
"     </li>",
"     <li>",
"      Post-normalization quality assessment evaluates a microarray relative to all others in the experiment. This helps to identify outlier samples or differences in batches of microarrays. Microarrays identified as significantly different from others can be adjusted statistically or excluded from the analysis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544131\">",
"    <span class=\"h4\">",
"     Preprocessing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many statistical procedures assume a normal distribution of data. Gene expression levels from microarrays can be mathematically transformed, often using a logarithmic scale, so that they become normally distributed. Preprocessing can also include filtering out low quality probe sets or genes with low variability across all samples in the experiment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H95557425\">",
"    <span class=\"h3\">",
"     Data storage and analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Microarray experiments require computational tools to store raw data, analyze gene expression, and ensure uniformity across different laboratories.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544145\">",
"    <span class=\"h4\">",
"     Data storage",
"    </span>",
"    &nbsp;&mdash;&nbsp;The fluorescent intensities generated by scanning an oligonucleotide array with a laser scanner results in an image file. Most scientific journals specify that raw data be made publicly available as a requirement for publication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/19\">",
"     19",
"    </a>",
"    ]. A typical microarray raw data file is 0.1-1GB per array, generating a large amount of data that must be stored [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/17\">",
"     17",
"    </a>",
"    ]. Beyond the storage of raw data, data files also include the clinical variables associated with each sample and the normalized, quality assessed preprocessed expression levels for each array. This is often accomplished with the use of a database capable of storing and integrating both gene expression data and clinical variables.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544152\">",
"    <span class=\"h4\">",
"     Data analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several possible levels of data analysis, ranging from simple statistical tests that can be performed with commercial software packages, to advanced analyses and the development of novel algorithms. Advanced analyses and novel algorithms are implemented with a variety of programming languages, such as Perl and Python, and computational software, such as R [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/20\">",
"     20",
"    </a>",
"    ] and Matlab [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/21\">",
"     21",
"    </a>",
"    ]. The flexibility to write, modify and share algorithms using these tools makes them particularly well suited for microarray data analysis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Differential expression &mdash; One of the most common analyses performed on microarray data is to determine which genes are altered in one condition as compared to another. This can be accomplished by performing a t-test, ANOVA, or linear model.",
"     </li>",
"     <li>",
"      Class prediction &mdash; In this type of analysis, samples from two conditions are split into a training set and a test set. A list of genes that distinguishes the two conditions is derived from the training set of samples, and the accuracy of this gene expression signature is assessed on the test set of samples.",
"     </li>",
"     <li>",
"      Class discovery &mdash; Microarray data can be used to explore novel molecular phenotypes. By taking the most variable genes across all samples regardless of their clinical phenotype, it can be determined which samples are most closely correlated with each other based on gene expression alone. Samples that share similar patterns of gene expression may represent previously unrecognized subtypes of the disease.",
"     </li>",
"     <li>",
"      Network analysis &mdash; The number of genes assayed by microarrays allows the entire dataset to be harnessed to make new predictions about how genes might interact. One approach, the Context Likelihood Relatedness (CLR) algorithm, uses a mathematical representation of the amount of information that one gene's expression gives about any other gene's expression [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/22\">",
"       22",
"      </a>",
"      ]. This can then be represented as a network of predicted interactions between genes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544159\">",
"    <span class=\"h3\">",
"     The multiple comparison problem",
"    </span>",
"    &nbsp;&mdash;&nbsp;Statistical analyses of several thousand genes pose unique problems in the interpretation of the statistical results because of the large number of tests performed.",
"   </p>",
"   <p>",
"    If a large number of statistical tests are performed, it is more likely that an individual test represents a false positive finding. In general, statistical tests ask whether two groups are similar (null hypothesis) or different (alternative hypothesis). Statistical tests estimate the certainty about choosing the alternative hypothesis over the null hypothesis. By incorrectly concluding that there is a difference between the groups where there is no actual difference, a Type I error has occurred and the result is falsely positive. The probability of making this error is estimated by the alpha level, or p-value. For a p value of 0.05, there is a 1 in 20 chance of making a Type I error. If one statistical test is performed for each of 10,000 genes from a microarray using a p-value of 0.05, there will be 500 Type I errors. In most circumstances, this is an unacceptably high number of false positives.",
"   </p>",
"   <p>",
"    Several methods exist to manage the multiple comparison problem.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bonferroni correction &mdash; This strict correction lowers the probability of making a Type I error. The desired alpha level is divided by the total number of tests to yield the p-value required for an individual test to reach statistical significance. For a family of 10,000 tests and a desired Type I error rate of 0.05, the adjusted p-value for an individual test to reach significance is",
"      <span class=\"nowrap\">",
"       0.05/10,000,",
"      </span>",
"      or 5*10(-6). While this method limits the number of false positives, it also makes real effects more difficult to detect.",
"     </li>",
"     <li>",
"      Benjamini-Hochberg false discovery rate &mdash; An alternative approach is to control the expected number of false positives [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/23\">",
"       23",
"      </a>",
"      ]. The false discovery rate (FDR) is the rate at which genes called significant are actually not significant [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/24\">",
"       24",
"      </a>",
"      ]. If 5000 genes are significant at certain p-value, and 500 false positives are expected at this p-value, the FDR is 0.1.",
"     </li>",
"     <li>",
"      Q-value &mdash; The third approach is an extension of the FDR approach [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/24\">",
"       24",
"      </a>",
"      ]. The q-value measures significance based upon the FDR [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/24\">",
"       24",
"      </a>",
"      ]. Whereas each gene's p-value indicates a certainty of a true difference expression, each gene's q-value indicates the fraction of false positives at this level. Hence, a q-value of 0.05 denotes that among genes with a q-value &le;0.05, all but 5 percent are likely true positive results. In this way, one can tolerate a small proportion of false positive results without having to ignore the much larger proportion (in this case, 95 percent) of true positive results.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544180\">",
"    <span class=\"h3\">",
"     Biological interpretation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The final step in microarray data analysis is to interpret the results in a biologically meaningful context. Making biological sense of a microarray-derived gene list is one of the more challenging aspects of the analysis. While there are many strategies for accomplishing this goal, two broad approaches are discussed below. Additional studies are often required to validate biological predictions that are made from the microarray data.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544187\">",
"    <span class=\"h4\">",
"     Comparison with other microarray datasets",
"    </span>",
"    &nbsp;&mdash;&nbsp;In one study in 2005, RNA was distributed to four laboratories for analysis by 12 different microarray platforms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/25\">",
"     25",
"    </a>",
"    ]. Good reproducibility was found within a laboratory, but there was decreased reproducibility across laboratories [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/25\">",
"     25",
"    </a>",
"    ]. Reproducibility improved with the use of standardized protocols for RNA labeling, hybridization, microarray processing, data acquisition and data normalization.",
"   </p>",
"   <p>",
"    Several tools exist for comparing gene expression datasets, including large databases containing gene expression data to look for a shared gene expression signature [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/26\">",
"     26",
"    </a>",
"    ], alternative gene probes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/27\">",
"     27",
"    </a>",
"    ], and analytic tools that incorporate phenotypic associations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/28-30\">",
"     28-30",
"    </a>",
"    ]",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544194\">",
"    <span class=\"h4\">",
"     Enrichment ranking",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gene set enrichment analysis (GSEA) is a method by which gene expression data is ranked by association with phenotypes, and is used as a means to identify biologically-relevant pathways [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Other techniques provide other mechanisms to enrich pathways or functional categories [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/31\">",
"     31",
"    </a>",
"    ] or to visualize previously published interactions between genes of interest [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/32\">",
"     32",
"    </a>",
"    ]. Data visualization using heat maps, which organize samples by columns and genes by rows according to similarity in gene expression, are also useful for determining which groups of genes or samples share similar patterns of expression.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544201\">",
"    <span class=\"h1\">",
"     OVERVIEW OF CLINICAL APPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Gene expression profiling within clinical specimens has the potential to be used for disease screening, diagnosis, prognostication, and optimizing treatment regimens. As the platforms for measuring gene expression continue to evolve, personalized approaches to the diagnosis and treatment of complex human disease will increasingly find their place in routine clinical practice.",
"   </p>",
"   <p>",
"    The promise of using gene expression profiling to identify subjects at risk for disease has yet to be fully reached. Several clinical applications of gene expression profiling to aid in diagnosis and prognostication have been reported. The use of gene expression profiling in clinical oncology is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/47/39674?source=see_link\">",
"     \"Overview of gene expression profiling, proteomics, and microRNA profiling in clinical oncology\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19682771\">",
"    <span class=\"h2\">",
"     Diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Two examples of the use of gene expression profiling to target selected patients for more invasive testing follow:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Current protocol calls for routine endomyocardial biopsy surveillance for cardiac transplant patients to detect the presence of acute cellular rejection. A study of gene expression profiling of RNA from peripheral blood mononuclear cells in heart transplant recipients revealed that an 11 gene expression profile could predict the presence of rejection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/33\">",
"       33",
"      </a>",
"      ]. Use of this gene expression profile has the potential to decrease the number of transplant patients who would need to undergo invasive myocardial biopsy to confirm the diagnosis of rejection. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/24/28040?source=see_link&amp;anchor=H17#H17\">",
"       \"Acute cardiac allograft rejection: Diagnosis\", section on 'Gene expression profiling'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Smokers suspected of having lung cancer on the basis of an abnormal chest CT scan often need to undergo invasive diagnostic procedures, beyond bronchoscopy, to achieve a final diagnosis. An 80 gene expression signature resulting from gene expression profiling of histologically normal airway epithelium obtained during bronchoscopy was capable of distinguishing between smokers with and without lung cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/34\">",
"       34",
"      </a>",
"      ]. Combining results of this gene expression biomarker with clinical variables, in an integrated clinico-genomic model, improved the discriminatory potential to predict lung cancer [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39799/abstract/34\">",
"       34",
"      </a>",
"      ]. Gene expression profiling may help to stratify patients with an abnormal chest CT scan who should undergo invasive diagnostic testing for a potential lung cancer and those for whom less intensive monitoring would be appropriate.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544236\">",
"    <span class=\"h2\">",
"     Prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most advanced application of gene expression profiling is in predicting outcome from disease. The risk of certain therapies might be outweighed by the potential benefit for patients at high risk for relapse or with a poor prognosis, whereas the risks might outweigh the benefits for patients with a relatively good prognosis. Gene expression profiling has been helpful in targeting appropriate therapy for patients with acute leukemia, prostate cancer, colon cancer, breast cancer, lung carcinoma, and lymphoma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/47/39674?source=see_link&amp;anchor=H13#H13\">",
"     \"Overview of gene expression profiling, proteomics, and microRNA profiling in clinical oncology\", section on 'Clinical applications of DNA microarrays'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Gene expression profiling is not widely used clinically. However, in certain circumstances this tool has been incorporated into routine clinical evaluation. As an example, the Oncotype Dx assay is used to guide the evaluation and management of subsets of patients with breast cancer. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/28/43465?source=see_link&amp;anchor=H29981488#H29981488\">",
"     \"Measurement of prognostic factors in breast cancer\", section on 'Multigene predictors of clinical outcome'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3544264\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There are a variety of methods for profiling RNA expression. These methods differ in their requirements for the amount of starting RNA, their sensitivity to detect the RNA of interest, and the computational requirements for data analysis. (See",
"      <a class=\"local\" href=\"#H3544024\">",
"       'Measuring gene expression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While oligonucleotide array profiling is the commonly used biomarker discovery platform, there are numerous challenges and pitfalls in the analysis and interpretation of the large volume of data generated. (See",
"      <a class=\"local\" href=\"#H3544103\">",
"       'Microarray analysis and interpretation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Gene expression profiling is rapidly emerging as a novel approach for the diagnosis and prognosis of complex human disease. However, a number of important barriers remain, including validation of these biomarkers in prospective multi-center studies to demonstrate their reproducibility and accuracy across multiple sites and operators. (See",
"      <a class=\"local\" href=\"#H3544201\">",
"       'Overview of clinical applications'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Brown TA. Genomes 3, 3rd ed, Garland Science, 2007.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/2\">",
"      Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993; 75:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/3\">",
"      Girard A, Sachidanandam R, Hannon GJ, Carmell MA. A germline-specific class of small RNAs binds mammalian Piwi proteins. Nature 2006; 442:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/4\">",
"      Aravin A, Gaidatzis D, Pfeffer S, et al. A novel class of small RNAs bind to MILI protein in mouse testes. Nature 2006; 442:203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/5\">",
"      Khalil AM, Guttman M, Huarte M, et al. Many human large intergenic noncoding RNAs associate with chromatin-modifying complexes and affect gene expression. Proc Natl Acad Sci U S A 2009; 106:11667.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/6\">",
"      Dvor&aacute;k Z, Pascussi JM, Modriansk&yacute; M. Approaches to messenger RNA detection - comparison of methods. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2003; 147:131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/7\">",
"      International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature 2004; 431:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/8\">",
"      Alwine JC, Kemp DJ, Stark GR. Method for detection of specific RNAs in agarose gels by transfer to diazobenzyloxymethyl-paper and hybridization with DNA probes. Proc Natl Acad Sci U S A 1977; 74:5350.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/9\">",
"      Gall JG, Pardue ML. Formation and detection of RNA-DNA hybrid molecules in cytological preparations. Proc Natl Acad Sci U S A 1969; 63:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/10\">",
"      Jin L, Lloyd RV. In situ hybridization: methods and applications. J Clin Lab Anal 1997; 11:2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/11\">",
"      Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/12\">",
"      Churchill GA. Fundamentals of experimental design for cDNA microarrays. Nat Genet 2002; 32 Suppl:490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/13\">",
"      Pease AC, Solas D, Sullivan EJ, et al. Light-generated oligonucleotide arrays for rapid DNA sequence analysis. Proc Natl Acad Sci U S A 1994; 91:5022.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/14\">",
"      Nuwaysir EF, Huang W, Albert TJ, et al. Gene expression analysis using oligonucleotide arrays produced by maskless photolithography. Genome Res 2002; 12:1749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/15\">",
"      Nolan T, Hands RE, Bustin SA. Quantification of mRNA using real-time RT-PCR. Nat Protoc 2006; 1:1559.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/16\">",
"      VanGuilder HD, Vrana KE, Freeman WM. Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 2008; 44:619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/17\">",
"      Wilhelm BT, Landry JR. RNA-Seq-quantitative measurement of expression through massively parallel RNA-sequencing. Methods 2009; 48:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/18\">",
"      Quackenbush J. Microarray data normalization and transformation. Nat Genet 2002; 32 Suppl:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/19\">",
"      Brazma A, Hingamp P, Quackenbush J, et al. Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 2001; 29:365.",
"     </a>",
"    </li>",
"    <li>",
"     R Development Core Team. R: A Language and Environment for Statistical Computing 2009. R Foundation for Statistical Computing. Available at: www.R-project.org (Accessed on December 14, 2009).",
"    </li>",
"    <li>",
"     The Mathworks I. The MathWorks - MATLAB and Simulink for Technical Computing 2009. Available at: www.mathworks.com (Accessed on December 14, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/22\">",
"      Faith JJ, Hayete B, Thaden JT, et al. Large-scale mapping and validation of Escherichia coli transcriptional regulation from a compendium of expression profiles. PLoS Biol 2007; 5:e8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/23\">",
"      Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc 1995; 57:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/24\">",
"      Storey JD, Tibshirani R. Statistical significance for genomewide studies. Proc Natl Acad Sci U S A 2003; 100:9440.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/25\">",
"      Bammler T, Beyer RP, Bhattacharya S, et al. Standardizing global gene expression analysis between laboratories and across platforms. Nat Methods 2005; 2:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/26\">",
"      Barrett T, Troup DB, Wilhite SE, et al. NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res 2009; 37:D885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/27\">",
"      Dai M, Wang P, Boyd AD, et al. Evolving gene/transcript definitions significantly alter the interpretation of GeneChip data. Nucleic Acids Res 2005; 33:e175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/28\">",
"      Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005; 102:15545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/29\">",
"      Mootha VK, Lindgren CM, Eriksson KF, et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 2003; 34:267.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/30\">",
"      Lamb J, Crawford ED, Peck D, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 2006; 313:1929.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/31\">",
"      Dennis G Jr, Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003; 4:P3.",
"     </a>",
"    </li>",
"    <li>",
"     Ingenuity Systems. Ingenuity Pathway Analysis Software 2009. Available at: www.ingenuity.com (Accessed on December 14, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/33\">",
"      Deng MC, Eisen HJ, Mehra MR, et al. Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling. Am J Transplant 2006; 6:150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39799/abstract/34\">",
"      Beane J, Sebastiani P, Whitfield TH, et al. A prediction model for lung cancer diagnosis that integrates genomic and clinical features. Cancer Prev Res (Phila) 2008; 1:56.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14602 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-189.2.19.178-485ACEB782-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39799=[""].join("\n");
var outline_f38_55_39799=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H3544264\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3544017\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H95557489\">",
"      RNA IN CELL FUNCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3544024\">",
"      MEASURING GENE EXPRESSION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3544040\">",
"      Early approaches",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3544047\">",
"      - Northern blot",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3544054\">",
"      - Ribonuclease protection assay",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3544061\">",
"      - In-situ hybridization",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3544068\">",
"      - Spotted cDNA arrays",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3544075\">",
"      Contemporary gene expression profiling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H95557895\">",
"      - Oligonucleotide arrays (microarrays)",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H95557343\">",
"      - Real-time reverse transcription polymerase chain reaction",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3544096\">",
"      - Transcriptome sequencing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3544103\">",
"      Microarray analysis and interpretation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3544110\">",
"      - Normalization, quality assessment, and preprocessing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3544117\">",
"      Normalization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3544124\">",
"      Quality assessment",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3544131\">",
"      Preprocessing",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H95557425\">",
"      - Data storage and analysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3544145\">",
"      Data storage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3544152\">",
"      Data analysis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3544159\">",
"      - The multiple comparison problem",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H3544180\">",
"      - Biological interpretation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3544187\">",
"      Comparison with other microarray datasets",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H3544194\">",
"      Enrichment ranking",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3544201\">",
"      OVERVIEW OF CLINICAL APPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19682771\">",
"      Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3544236\">",
"      Prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3544264\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PC/14602\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/14602|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?39/61/40926\" title=\"figure 1\">",
"      Central dogma molecular bio",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/43/22193\" title=\"figure 2\">",
"      mRNA processing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/22/3424\" title=\"figure 3\">",
"      Microarray analysis strategy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PC/14602|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?26/61/27613\" title=\"table 1\">",
"      Methods to quantify gene expression",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/24/28040?source=related_link\">",
"      Acute cardiac allograft rejection: Diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/28/43465?source=related_link\">",
"      Measurement of prognostic factors in breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/47/39674?source=related_link\">",
"      Overview of gene expression profiling, proteomics, and microRNA profiling in clinical oncology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/27/17846?source=related_link\">",
"      Principles of molecular genetics",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_55_39800="Overview of preoperative evaluation and preparation for gynecologic surgery";
var content_f38_55_39800=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Overview of preoperative evaluation and preparation for gynecologic surgery",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/55/39800/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/55/39800/contributors\">",
"     William J Mann, Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/55/39800/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/55/39800/contributors\">",
"     Tommaso Falcone, MD, FRCSC, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/55/39800/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/55/39800/contributors\">",
"     Sandy J Falk, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/55/39800/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 1, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preoperative evaluation and preparation prior to gynecologic surgery addresses issues that will potentially affect the woman during her surgical procedure and recovery. The surgeon should use this time to review the patient's history and physical examination, identify physical limitations, gather information required to plan surgery, optimize medical status, and educate about what to expect from the procedure and during the recovery period.",
"   </p>",
"   <p>",
"    Many postoperative problems can be anticipated preoperatively, and eliminated or minimized; systematically addressing these issues at the preoperative evaluation may result in a shorter hospitalization with fewer complications and a more satisfied patient. The surgeon may also rethink the aggressiveness and necessity of a planned operative procedure after thoughtful discussion with patients who have severe medical problems. As an example, a woman with symptomatic congestive heart failure and uterine procidentia may be better served with a pessary than by vaginal hysterectomy and sacrospinous suspension. This discussion is mainly regarding scheduled surgery. Urgent cases require an expedited preoperative evaluation process to provide appropriate care.",
"   </p>",
"   <p>",
"    The preoperative evaluation and preparation of women for gynecologic surgery will be reviewed here. General principles of preoperative evaluation and preparation are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/48/41735?source=see_link\">",
"     \"Overview of the principles of medical consultation and perioperative medicine\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/4/10314?source=see_link\">",
"     \"Preoperative medical evaluation of the healthy patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INFORMED CONSENT AND PATIENT EXPECTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preoperative process should include comprehensive counseling of the patient regarding alternative treatment options (including expectant management) and risks and benefits of the procedure. For some procedures, particularly those that have variable outcomes and impact quality of life (eg, pelvic organ prolapse repair), patient expectations and goals should be discussed in detail. The expected duration and requirements of the recovery period should also be reviewed. Anticipatory guidance during preoperative office visits will enhance a patient's acceptance and compliance during the immediate postoperative period and may help to shorten hospital stay [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The surgeon should confirm that the patient has understood the discussion and desires to proceed with the procedure. This discussion should be documented in the medical record and on the procedure consent form.",
"   </p>",
"   <p>",
"    Informed consent is discussed in detail separately, including issues related to incompetent or incapacitated patients, adolescent patients, and issues regarding patients who refuse blood transfusion. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/5/43094?source=see_link\">",
"     \"Informed consent\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/24/5512?source=see_link\">",
"     \"Consent in adolescent health care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/46/10986?source=see_link\">",
"     \"The approach to the patient who refuses blood transfusion\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     PREOPERATIVE EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative evaluation should identify areas that may emerge as intraoperative or postoperative problems. The surgeon can use this information to prepare the woman for surgery and plan for any perioperative measures needed to avoid or manage complications. &nbsp;",
"   </p>",
"   <p>",
"    An overview of the evaluation of a patient prior to gynecologic surgery is discussed in this section. The preoperative evaluation of a healthy patient for any type of surgery is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/4/10314?source=see_link\">",
"     \"Preoperative medical evaluation of the healthy patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2370093\">",
"    <span class=\"h2\">",
"     History",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preoperative medical history should include the basic elements of the history (medical conditions, surgical history, medications, allergies), as well as those related to the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Medical condition for which the procedure is performed",
"     </li>",
"     <li>",
"      Medical conditions and risk factors that increase the risk of perioperative complications",
"     </li>",
"     <li>",
"      Personal or family history or risk factors for thromboembolism",
"     </li>",
"     <li>",
"      Personal or family history of anesthesia-related complications",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    General questions for the preoperative patient are shown in the table (",
"    <a class=\"graphic graphic_table graphicRef66690 \" href=\"mobipreview.htm?37/36/38475\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2371967\">",
"    <span class=\"h3\">",
"     Medical comorbidities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women with known or suspected medical comorbidities should be identified prior to surgery and referred for appropriate consultation regarding surgical clearance and perioperative management. These issues are discussed in detail separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?40/48/41735?source=see_link\">",
"       \"Overview of the principles of medical consultation and perioperative medicine\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/60/36810?source=see_link\">",
"       \"Estimation of cardiac risk prior to noncardiac surgery\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/17/33046?source=see_link\">",
"       \"Perioperative management of hypertension\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?1/8/1162?source=see_link\">",
"       \"Evaluation of preoperative pulmonary risk\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35288?source=see_link\">",
"       \"Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/63/29688?source=see_link\">",
"       \"Perioperative management of diabetes mellitus\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/47/36601?source=see_link\">",
"       \"Medical management of the dialysis patient undergoing surgery\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?12/35/12858?source=see_link\">",
"       \"Assessing surgical risk in patients with liver disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?10/9/10394?source=see_link\">",
"       \"Perioperative care of the surgical patient with neurologic disease\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2370101\">",
"    <span class=\"h2\">",
"     Physical examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prior to gynecologic surgery, a complete pelvic examination should be performed by the surgeon. In many cases, the pelvic examination is repeated after induction of anesthesia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/43/42681?source=see_link\">",
"     \"The gynecologic history and pelvic examination\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/1/20499?source=see_link\">",
"     \"Pelvic examination under anesthesia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Further components of the physical examination should be performed that are related to the condition for which the procedure is performed. As an example, if malignancy is suspected, the preoperative examination should include site of potential lymph node metastases. In addition, the physical examination should be used to evaluate the patient&rsquo;s ability to tolerate surgery or anesthesia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Further testing of the preoperative patient depends upon the procedure and medical comorbidities. Routine testing in healthy preoperative patients is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/4/10314?source=see_link\">",
"     \"Preoperative medical evaluation of the healthy patient\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Pregnancy test",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnancy testing should be performed prior to gynecologic surgery in all women of reproductive age. This also applies to patients for whom there is uncertainty about sexual activity, effectiveness of contraception, or about menopausal status. If the patient is pregnant, procedures that may cause fetal harm or loss should be cancelled or postponed. Decisions regarding nonelective procedures that do not interfere with the pregnancy should be individualized and surgical planning should include measures to safeguard and monitor the pregnancy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/4/10314?source=see_link&amp;anchor=H2750321#H2750321\">",
"     \"Preoperative medical evaluation of the healthy patient\", section on 'Pregnancy testing'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prevalence of unrecognized pregnancy was illustrated in a prospective study that performed pregnancy tests on all women of childbearing potential (defined as menstruating women without prior hysterectomy or tubal ligation) scheduled for ambulatory surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/2\">",
"     2",
"    </a>",
"    ]. Testing revealed 7 previously unrecognized pregnancies in 2056 women (0.3 percent), including 2 patients scheduled to undergo fertility procedures. All of the pregnant women cancelled or postponed their procedures.",
"   </p>",
"   <p>",
"    Issues regarding surgical procedures in pregnant women are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/7/15482?source=see_link\">",
"     \"Management of pregnant women undergoing nonobstetric surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2370322\">",
"    <span class=\"h3\">",
"     Testing for genital tract infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative screening for genital tract infections is generally not necessary; women with symptoms or risk factors for infections should be tested and treated as part of usual gynecologic care. Certain types of infections are clinically important for particular procedures, including:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Bacterial vaginosis is associated with an increased risk of vaginal cuff infection following hysterectomy. Women with symptoms or pelvic examination findings consistent with bacterial vaginosis should be evaluated and treated prior to hysterectomy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=see_link&amp;anchor=H17#H17\">",
"       \"Bacterial vaginosis\", section on 'Gynecologic procedures'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Cervical infections with",
"      <em>",
"       Chlamydia trachomatis",
"      </em>",
"      or",
"      <em>",
"       Neisseria gonorrhea",
"      </em>",
"      are associated with an increased risk of endometritis following surgical pregnancy termination. These infections are managed with universal use of prophylactic antibiotics prior to the procedure rather than a screen and treat strategy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/2/19498?source=see_link&amp;anchor=H8#H8\">",
"       \"Overview of pregnancy termination\", section on 'Antibiotic prophylaxis'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19013318\">",
"    <span class=\"h2\">",
"     Other testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other testing (eg, pelvic imaging) should be performed as needed based upon the indication and procedure. Routine pelvic imaging is not required if there is no clinical indication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     PREOPERATIVE PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative preparation includes issues that are addressed in the clinic and operating room prior to surgery.",
"   </p>",
"   <p>",
"    Operating room safety is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/37/33369?source=see_link\">",
"     \"Operating room safety\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2371328\">",
"    <span class=\"h2\">",
"     Medication management",
"    </span>",
"    &nbsp;&mdash;&nbsp;A discussion of perioperative medication management can be found separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?39/45/40666?source=see_link\">",
"     \"Perioperative medication management\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2372185\">",
"    <span class=\"h2\">",
"     Blood loss preparation",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Correction of anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preoperative correction of anemia for gynecologic surgery is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/18/43305?source=see_link\">",
"     \"Management of hemorrhage in gynecologic surgery\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/18/43305?source=see_link&amp;anchor=H7#H7\">",
"     \"Management of hemorrhage in gynecologic surgery\", section on 'Correction of anemia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2371445\">",
"    <span class=\"h3\">",
"     Autologous blood transfusion",
"    </span>",
"    &nbsp;&mdash;&nbsp;If significant blood loss is anticipated, preoperative preparations can be made to use autologous blood in the event a transfusion is necessary. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/18/43305?source=see_link&amp;anchor=H8#H8\">",
"     \"Management of hemorrhage in gynecologic surgery\", section on 'Autologous transfusion methods'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8420449\">",
"    <span class=\"h2\">",
"     Wrong person, site, procedure prevention",
"    </span>",
"    &nbsp;&mdash;&nbsp;Practicing safe, high-quality operating room care begins with accurately identifying the patient, surgical site, and procedure. The United States Joint Commission on Accreditation of Healthcare Organizations (JCAHO) Universal Protocol for Preventing Wrong Site, Wrong Procedure, Wrong Person Surgery is shown in the table (",
"    <a class=\"graphic graphic_table graphicRef59666 \" href=\"mobipreview.htm?39/28/40395\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/37/33369?source=see_link&amp;anchor=H698033#H698033\">",
"     \"Operating room safety\", section on 'Correct patient, site, and procedure'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2371663\">",
"    <span class=\"h2\">",
"     Smoking cessation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The preoperative evaluation provides an opportunity to discuss the benefits of smoking cessation. Current cigarette smokers have an increased risk for postoperative pulmonary complications, although the incremental risk is small in the absence of chronic lung disease. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/51/13113?source=see_link&amp;anchor=H4#H4\">",
"     \"Strategies to reduce postoperative pulmonary complications\", section on 'Smoking cessation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H67153299\">",
"    <span class=\"h1\">",
"     SURGICAL SITE INFECTION PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most important factors in the prevention of surgical site infection are timely administration of effective preoperative antibiotics and meticulous operative technique.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17330349\">",
"    <span class=\"h2\">",
"     Antibiotic prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Antibiotics should be given prior to gynecologic surgery or procedures to prevent surgical site infection when the reproductive tract is entered (eg, hysterectomy) or there is likely to be contamination of the peritoneal cavity from the vagina (eg, surgical abortion, hysterosalpingogram in patients with risk factors for infection). &nbsp;",
"   </p>",
"   <p>",
"    Guidelines from the American College of Obstetricians and Gynecologists (ACOG) are shown in the table (",
"    <a class=\"graphic graphic_table graphicRef87200 \" href=\"mobipreview.htm?12/1/12317\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/4\">",
"     4",
"    </a>",
"    ]. General principles of surgical site infection prevention have been published by the United States Centers for Disease Control and Prevention (CDC) (",
"    <a class=\"graphic graphic_table graphicRef58579 \" href=\"mobipreview.htm?17/31/17916\">",
"     table 4",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Prevention of surgical site infection is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=see_link\">",
"     \"Overview of control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17329958\">",
"    <span class=\"h2\">",
"     Other measures",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prevention of surgical site infection includes other measures in addition to antibiotics. These include skin antisepsis, hair removal, drapes, surgical hand hygiene, and surgical technique. Vaginal preparation is discussed here; other measures are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of control measures to prevent surgical site infection\", section on 'General principles'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/35/10805?source=see_link\">",
"     \"Controversies in control measures to prevent surgical site infection\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17329983\">",
"    <span class=\"h3\">",
"     Vaginal preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;We suggest sterile preparation of the vagina if a procedure includes a vaginal incision or transvaginal use of instruments. There is no high-quality evidence to confirm that vaginal preparation alone or in addition to antibiotics contributes to surgical site infection prevention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/6-8\">",
"     6-8",
"    </a>",
"    ]. The risk of ascending infection is well-established, however, in pelvic inflammatory disease, and the risks of vaginal preparation are limited to an adverse reaction to the agent used for preparation in patients with an unrecognized sensitivity to this agent.",
"   </p>",
"   <p>",
"    Povidone-iodine solution is generally used for vaginal preparation. Some surgeons use povidone-iodine gel in addition to solution, but there are conflicting data regarding this practice. It appears that bacterial counts return to near baseline levels within 30 minutes after vaginal painting with povidone&ndash;iodine solution; however, vaginal povidone&ndash;iodine gel lowers bacterial counts for at least three hours [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/9\">",
"     9",
"    </a>",
"    ]. Randomized trials have yielded inconsistent results regarding whether vaginal preparation with povidone-iodine in both solution and gel form compared with solution alone reduces the overall risk of postoperative infectious morbidity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/6,10\">",
"     6,10",
"    </a>",
"    ]. One trial found that combined use of solution and gel reduced the risk of postoperative pelvic abscess [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <br/>",
"    For women who are allergic to iodine, it is unclear whether it is preferable to use",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/36/12870?source=see_link\">",
"     chlorhexidine",
"    </a>",
"    or sterile saline for vaginal preparation. Chlorhexidine provides antisepsis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/11\">",
"     11",
"    </a>",
"    ], while saline does not. However, the safety of chlorhexidine has been questioned. Manufacturer labelling of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?12/36/12870?source=see_link\">",
"     chlorhexidine gluconate",
"    </a>",
"    (Hibiclens) states that irritation, sensitization, and generalized allergic reactions have been reported with use in the genital areas and a case has been reported of vaginal desquamation after application of chlorhexidine gluconate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. In contrast, no significant adverse effects were reported in several studies, including over 7000 women, in which chlorhexidine was used vaginally [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/14-18\">",
"     14-18",
"    </a>",
"    ]. Some institutions prohibit the use of chlorhexidine for vaginal preparation, and thus, saline is used. In our practice, if a saline preparation is used and the peritoneal cavity is entered, we use prophylactic antibiotics and irrigate the field thoroughly at the conclusion of the case. If the procedure does not usually require prophylactic antibiotics, the risk of surgical site infection must be weighed against the risks of Clostridium difficile infection and antibiotic resistance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17332175\">",
"    <span class=\"h1\">",
"     THROMBOPROPHYLAXIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of venous thromboembolism (VTE, ie, deep vein thrombosis [DVT] or pulmonary embolism) is significantly increased during and after surgery. Surgery and other risk factors associated with higher rates of thrombosis are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef59759 \" href=\"mobipreview.htm?1/6/1132\">",
"     table 5",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/48/43786?source=see_link\">",
"     \"Overview of the causes of venous thrombosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thromboprophylaxis reduces the incidence of symptomatic DVT or pulmonary embolism. Decisions regarding the method, dose, and timing of prophylaxis depend upon balancing a patient's risk thrombosis versus perioperative bleeding.",
"   </p>",
"   <p>",
"    The use of thromboprophylaxis for patients undergoing surgery can be found separately. Issues particular to gynecologic surgery are discussed here. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=see_link\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The most highly regarded guidelines regarding perioperative thromboprophylaxis are published by the American College of Chest Physicians (ACCP) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/19\">",
"     19",
"    </a>",
"    ]. Based on the ACCP guidelines, surgical patients are classified into risk categories (",
"    <a class=\"graphic graphic_table graphicRef83739 \" href=\"mobipreview.htm?22/50/23341\">",
"     table 6",
"    </a>",
"    ). Use of thromboprophylaxis is then guided by the risk category. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=see_link&amp;anchor=H5#H5\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\", section on 'Surgical risk groups'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=see_link&amp;anchor=H34#H34\">",
"     \"Prevention of venous thromboembolic disease in surgical patients\", section on 'Group specific recommendations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Issues in gynecologic surgery patients that may increase the risk of thromboembolism include pregnancy, use of hormonal contraceptives or postmenopausal hormone therapy, and gynecologic malignancy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/20\">",
"     20",
"    </a>",
"    ]. These factors are included in the risk classification.",
"   </p>",
"   <p>",
"    The ACCP guidelines differ somewhat from the guidelines from the American College of Obstetricians and Gynecologists (ACOG) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/21\">",
"     21",
"    </a>",
"    ]. Both guidelines define a minor procedure as lasting less than 30 minutes, however, the ACCP differentiates between open and laparoscopic surgery, effectively classifying all entirely laparoscopic procedures as minor (regardless of duration or complexity). The ACOG guidelines divide patients into risk categories according to duration of surgery, age cut-offs (&lt;40 years, 40 to 60 years, and &gt;60 years), and individual VTE risk factors that are either not evidence-based or are based on data which are 25 or more years old [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Regarding laparoscopic surgery, some of the considerations are that abdominal wall tissue trauma is decreased with a laparoscopic approach, but activation of the coagulation system is similar to laparotomy. In addition, laparoscopic procedures may be as long or longer than open surgeries, and the use of pneumoperitoneum and reverse Trendelenburg contribute to venous stasis and, possibly, thrombosis. However, patients regain mobility more rapidly after laparoscopy compared with laparotomy.",
"   </p>",
"   <p>",
"    There are no high-quality studies which have addressed the question of thromboprophylaxis for gynecologic laparoscopy. In a retrospective study of over 10,000 women after hysterectomy, the rate of women who received thromboprophylaxis varied somewhat for those undergoing a laparoscopic, abdominal, or vaginal procedure (22, 38, or 47 percent, respectively); the incidence of VTE for the three procedures did not differ significantly (0.3, 0.2 or 0.2 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/22\">",
"     22",
"    </a>",
"    ]. Another retrospective review of over 800 patients who underwent gynecologic laparoscopy for benign or malignant indications reported that the rate of VTE increased with increasing complexity of the procedure: low (diagnostic laparoscopy; no VTE events); intermediate (ovarian cystectomy, salpingo-oophorectomy, tubal ligation, hysterectomy; 0.5 percent); and high (radical hysterectomy, lymphadenectomy, splenectomy, small",
"    <span class=\"nowrap\">",
"     bowel/colon",
"    </span>",
"    resection; 2.8 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/23\">",
"     23",
"    </a>",
"    ]. Interestingly, malignancy was not significantly associated with an increased risk of VTE, but this was likely because there were only six VTE events. Further study is needed.",
"   </p>",
"   <p>",
"    The management of women already on anticoagulants for coexistent conditions is reviewed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/50/35626?source=see_link\">",
"     \"Management of anticoagulation before and after elective surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8420754\">",
"    <span class=\"h1\">",
"     MEASURES FOR SELECTED USE OR THAT ARE NO LONGER RECOMMENDED",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8420876\">",
"    <span class=\"h2\">",
"     Stress dose glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;Use of stress doses of glucocorticoids has become a common perioperative practice for patients on glucocorticoid therapy. However, use of &ldquo;stress dose&rdquo; glucocorticoids is not necessary for all patients with recent glucocorticoid use. The current approach is to determine glucocorticoid coverage based upon the patient&rsquo;s history of glucocorticoid intake, as well as the type and duration of surgery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/62/17384?source=see_link\">",
"     \"The surgical patient taking glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8420779\">",
"    <span class=\"h2\">",
"     Bowel preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bowel preparation is no longer standard practice prior to gynecologic surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/24\">",
"     24",
"    </a>",
"    ]. Traditionally, bowel preparation was performed prior to procedures with the potential for injury to the bowel (eg, patients with advanced endometriosis, staging for gynecologic malignancies). This approach to bowel preparation included fasting and a mechanical bowel preparation. Most surgical programs have omitted bowel cleansing, favoring no preparation other than a preoperative enema if a left-sided colon resection is anticipated. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/23/16762?source=see_link&amp;anchor=H125365066#H125365066\">",
"     \"Surgical oncologic principles for the resection of colon cancer\", section on 'Bowel preparation'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8420953\">",
"    <span class=\"h2\">",
"     Endocarditis prophylaxis",
"    </span>",
"    &nbsp;&mdash;&nbsp;The American Heart Association (AHA) guidelines do not classify any gynecologic procedures as high risk for resulting in infective endocarditis and therefore do not recommend routine use of antibiotic prophylaxis, even in patients with the highest risk cardiac conditions. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/36/585?source=see_link&amp;anchor=H22969468#H22969468\">",
"     \"Antimicrobial prophylaxis for bacterial endocarditis\", section on 'Guidelines'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2372356\">",
"    <span class=\"h1\">",
"     SPECIAL ISSUES",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17997060\">",
"    <span class=\"h2\">",
"     Suspected malignancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;If gynecologic malignancy is suspected, the surgery should be performed by a surgeon with experience with surgical staging, typically a gynecologic oncologist. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/11/30905?source=see_link&amp;anchor=H15998736#H15998736\">",
"     \"Management of an adnexal mass\", section on 'Referral to a specialist'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?31/46/32490?source=see_link&amp;anchor=H33#H33\">",
"     \"Abdominal hysterectomy\", section on 'Malignancy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2372365\">",
"    <span class=\"h2\">",
"     Older adults",
"    </span>",
"    &nbsp;&mdash;&nbsp;The number of women over the age of 65 years will grow from 32 million in 1990 to 40 million in 2010 and 75 million in 2050 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/25\">",
"     25",
"    </a>",
"    ]. Consequently, the gynecologic surgeon must develop competency dealing with geriatric surgical patients. In the United States, a 75-year-old female can expect an additional 12.4 years of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/26\">",
"     26",
"    </a>",
"    ]. During most of these years, the women will be functional and independent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Age alone is not a contraindication to surgery. Decisions on operability should be based upon health status and discussion of treatment options with the patient; family members or other caregivers should be involved if they participate in the care of the patient [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39800/abstract/28,29\">",
"     28,29",
"    </a>",
"    ]. Appropriate preoperative medical consultations should be obtained to address medical comorbidities. (See",
"    <a class=\"local\" href=\"#H2371967\">",
"     'Medical comorbidities'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The evaluation of the status of the older adults and management of anesthesia and hospital care in this patient population are discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/38/43624?source=see_link\">",
"     \"Comprehensive geriatric assessment\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/61/15322?source=see_link\">",
"     \"Hospital management of older adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2372373\">",
"    <span class=\"h2\">",
"     Obesity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preparation of obese women for surgery should include evaluation for comorbidities that may increase the risk of perioperative complications (eg, obstructive sleep apnea, cardiac disease) and relevant surgical planning (eg, choice of incision, special equipment needs).",
"   </p>",
"   <p>",
"    Management of anesthesia in obese patients is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/41/35482?source=see_link\">",
"     \"Anesthesia for the obese patient undergoing non-cardiac surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2372381\">",
"    <span class=\"h2\">",
"     Orthopedic issues or physical disabilities",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women planning gynecologic surgery should be asked about orthopedic issues (eg, chronic back pain, recent hip or knee surgery) that may affect positioning during surgery. Appropriate positioning to avoid neural injury is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/3/3129?source=see_link\">",
"     \"Nerve injury associated with pelvic surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women with physical disabilities may require perioperative accommodations, including alternative positions or equipment. In addition, limited mobility is a risk factor for thromboembolism. Planning for surgery should include discussions with the patient, her caregivers and operating room personnel with experience with the logistics and regulations regarding these issues. Consultation regarding thromboprophylaxis should be obtained, if necessary. (See",
"    <a class=\"local\" href=\"#H17332175\">",
"     'Thromboprophylaxis'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/52/30530?source=see_link\">",
"       \"Patient information: Questions to ask if you are having a procedure or surgery (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H44\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The preoperative evaluation and preparation for gynecologic surgery addresses issues that will potentially affect the woman during her surgical procedure and recovery. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The informed consent process should include comprehensive counseling of the patient regarding alternative treatment options (including expectant management) and risks and benefits of the procedure. Patient expectations and goals and the expected duration and requirements of the recovery period should also be reviewed. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Informed consent and patient expectations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The preoperative evaluation should include a medical and surgical history, medications, and allergies, as well as a detailed history regarding the indication for the procedure and risk factors for surgical or anesthetic complications. A focused physical examination should be performed. (See",
"      <a class=\"local\" href=\"#H2370093\">",
"       'History'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2370101\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Medical consultation should be obtained for patients with medical comorbidities and regarding perioperative management of medications. (See",
"      <a class=\"local\" href=\"#H2371967\">",
"       'Medical comorbidities'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H2371328\">",
"       'Medication management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Pregnancy testing should be performed prior to gynecologic surgery in all women of reproductive age.",
"     </li>",
"     <li>",
"      Preoperative screening for genital tract infections is generally not necessary. The exception to this is bacterial vaginosis; women with symptoms or pelvic examination findings consistent with bacterial vaginosis should be evaluated and treated prior to hysterectomy. (See",
"      <a class=\"local\" href=\"#H2370322\">",
"       'Testing for genital tract infection'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Use of &ldquo;stress dose&rdquo; glucocorticoids is not necessary for all patients with recent glucocorticoid use. The current approach is to determine glucocorticoid coverage based upon the patient&rsquo;s history of glucocorticoid intake, as well as the type and duration of surgery. (See",
"      <a class=\"local\" href=\"#H8420876\">",
"       'Stress dose glucocorticoids'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Bowel preparation is not required prior to gynecologic surgery. (See",
"      <a class=\"local\" href=\"#H8420779\">",
"       'Bowel preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Antibiotics should be given prior to gynecologic procedures to prevent surgical site infection if the reproductive tract is entered (eg, hysterectomy) or there is likely to be contamination of the peritoneal cavity from the vagina (eg, surgical abortion, hysterosalpingogram in patients with risk factors for infection) (",
"      <a class=\"graphic graphic_table graphicRef87200 \" href=\"mobipreview.htm?12/1/12317\">",
"       table 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      We suggest sterile preparation of the vagina if a procedure includes a vaginal incision or transvaginal use of instruments (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17329983\">",
"       'Vaginal preparation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Use of thromboprophylaxis is guided by the risk category based on characteristics of the patient and procedure (",
"      <a class=\"graphic graphic_table graphicRef83739 \" href=\"mobipreview.htm?22/50/23341\">",
"       table 6",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H17332175\">",
"       'Thromboprophylaxis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/1\">",
"      Kehlet H, Wilmore DW. Multimodal strategies to improve surgical outcome. Am J Surg 2002; 183:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/2\">",
"      Manley S, de Kelaita G, Joseph NJ, et al. Preoperative pregnancy testing in ambulatory surgery. Incidence and impact of positive results. Anesthesiology 1995; 83:690.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/3\">",
"      Ramm O, Gleason JL, Segal S, et al. Utility of preoperative endometrial assessment in asymptomatic women undergoing hysterectomy for pelvic floor dysfunction. Int Urogynecol J 2012; 23:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/4\">",
"      ACOG Committee on Practice Bulletins--Gynecology. ACOG practice bulletin No. 104: antibiotic prophylaxis for gynecologic procedures. Obstet Gynecol 2009; 113:1180.",
"     </a>",
"    </li>",
"    <li>",
"     www.cdc.gov/ncidod/dhqp/gl_surgicalsite.html. (Accessed on October 22, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/6\">",
"      Eason E, Wells G, Garber G, et al. Antisepsis for abdominal hysterectomy: a randomised controlled trial of povidone-iodine gel. BJOG 2004; 111:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/7\">",
"      Amstey MS, Jones AP. Preparation of the vagina for surgery. A comparison of povidone-iodine and saline solution. JAMA 1981; 245:839.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/8\">",
"      Lewis LA, Lathi RB, Crochet P, Nezhat C. Preoperative vaginal preparation with baby shampoo compared with povidone-iodine before gynecologic procedures. J Minim Invasive Gynecol 2007; 14:736.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/9\">",
"      Monif GR, Thompson JL, Stephens HD, Baer H. Quantitative and qualitative effects of povidone-iodine liquid and gel on the aerobic and anaerobic flora of the female genital tract. Am J Obstet Gynecol 1980; 137:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/10\">",
"      Buppasiri P, Chongsomchai C, Wongproamas N, et al. Effectiveness of vaginal douching on febrile and infectious morbidities after total abdominal hysterectomy: a multicenter randomized controlled trial. J Med Assoc Thai 2004; 87:16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/11\">",
"      Wenzel RP. Minimizing surgical-site infections. N Engl J Med 2010; 362:75.",
"     </a>",
"    </li>",
"    <li>",
"     file://www.hibigeebies.com/about_safety.asp (Accessed on September 14, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/13\">",
"      Shippey SH, Malan TK. Desquamating vaginal mucosa from chlorhexidine gluconate. Obstet Gynecol 2004; 103:1048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/14\">",
"      Culligan PJ, Kubik K, Murphy M, et al. A randomized trial that compared povidone iodine and chlorhexidine as antiseptics for vaginal hysterectomy. Am J Obstet Gynecol 2005; 192:422.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/15\">",
"      Biggar RJ, Miotti PG, Taha TE, et al. Perinatal intervention trial in Africa: effect of a birth canal cleansing intervention to prevent HIV transmission. Lancet 1996; 347:1647.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/16\">",
"      Rouse DJ, Hauth JC, Andrews WW, et al. Chlorhexidine vaginal irrigation for the prevention of peripartal infection: a placebo-controlled randomized clinical trial. Am J Obstet Gynecol 1997; 176:617.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/17\">",
"      Gaillard P, Mwanyumba F, Verhofstede C, et al. Vaginal lavage with chlorhexidine during labour to reduce mother-to-child HIV transmission: clinical trial in Mombasa, Kenya. AIDS 2001; 15:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/18\">",
"      Saleem S, Rouse DJ, McClure EM, et al. Chlorhexidine vaginal and infant wipes to reduce perinatal mortality and morbidity: a randomized controlled trial. Obstet Gynecol 2010; 115:1225.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/19\">",
"      Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e227S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/20\">",
"      Clarke-Pearson DL, Abaid LN. Prevention of venous thromboembolic events after gynecologic surgery. Obstet Gynecol 2012; 119:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/21\">",
"      Committee on Practice Bulletins--Gynecology, American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 84: Prevention of deep vein thrombosis and pulmonary embolism. Obstet Gynecol 2007; 110:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/22\">",
"      M&auml;kinen J, Johansson J, Tom&aacute;s C, et al. Morbidity of 10 110 hysterectomies by type of approach. Hum Reprod 2001; 16:1473.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/23\">",
"      Nick AM, Schmeler KM, Frumovitz MM, et al. Risk of thromboembolic disease in patients undergoing laparoscopic gynecologic surgery. Obstet Gynecol 2010; 116:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/24\">",
"      Fanning J, Valea FA. Perioperative bowel management for gynecologic surgery. Am J Obstet Gynecol 2011; 205:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/25\">",
"      Markus GR. The graying of America: major Social Security and Medicare battles are just beginning. Bull Am Coll Surg 1997; 82:25.",
"     </a>",
"    </li>",
"    <li>",
"     National Center for Health Statistics. www.cdc.gov/nchs/data/hus/tables/2003/03hus027.pdf. (Accessed on March 08, 2005).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/27\">",
"      Guralnik JM, Land KC, Blazer D, et al. Educational status and active life expectancy among older blacks and whites. N Engl J Med 1993; 329:110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/28\">",
"      Lubin MF. Is age a risk factor for surgery? Med Clin North Am 1993; 77:327.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39800/abstract/29\">",
"      Parker DY, Burke JJ 2nd, Gallup DG. Gynecological surgery in octogenarians and nonagenarians. Am J Obstet Gynecol 2004; 190:1401.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 3301 Version 16.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.150.3.100-EF161DC620-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39800=[""].join("\n");
var outline_f38_55_39800=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H44\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INFORMED CONSENT AND PATIENT EXPECTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      PREOPERATIVE EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2370093\">",
"      History",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2371967\">",
"      - Medical comorbidities",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2370101\">",
"      Physical examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Pregnancy test",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2370322\">",
"      - Testing for genital tract infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19013318\">",
"      Other testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      PREOPERATIVE PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2371328\">",
"      Medication management",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2372185\">",
"      Blood loss preparation",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Correction of anemia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H2371445\">",
"      - Autologous blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8420449\">",
"      Wrong person, site, procedure prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2371663\">",
"      Smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H67153299\">",
"      SURGICAL SITE INFECTION PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17330349\">",
"      Antibiotic prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17329958\">",
"      Other measures",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17329983\">",
"      - Vaginal preparation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17332175\">",
"      THROMBOPROPHYLAXIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8420754\">",
"      MEASURES FOR SELECTED USE OR THAT ARE NO LONGER RECOMMENDED",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8420876\">",
"      Stress dose glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8420779\">",
"      Bowel preparation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8420953\">",
"      Endocarditis prophylaxis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2372356\">",
"      SPECIAL ISSUES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17997060\">",
"      Suspected malignancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2372365\">",
"      Older adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2372373\">",
"      Obesity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2372381\">",
"      Orthopedic issues or physical disabilities",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H44\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/3301\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/3301|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?37/36/38475\" title=\"table 1\">",
"      Preop evaluation questions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?39/28/40395\" title=\"table 2\">",
"      JCAHO protocol for surgical timeout",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/1/12317\" title=\"table 3\">",
"      Antimicrobial prophylaxis for gynecologic and obstetric surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/31/17916\" title=\"table 4\">",
"      Best pract infection prevention",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?1/6/1132\" title=\"table 5\">",
"      Causes of venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?22/50/23341\" title=\"table 6\">",
"      Caprini risk assessment model",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?31/46/32490?source=related_link\">",
"      Abdominal hysterectomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/41/35482?source=related_link\">",
"      Anesthesia for the obese patient undergoing non-cardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/36/585?source=related_link\">",
"      Antimicrobial prophylaxis for bacterial endocarditis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/35/12858?source=related_link\">",
"      Assessing surgical risk in patients with liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/56/30602?source=related_link\">",
"      Bacterial vaginosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/38/43624?source=related_link\">",
"      Comprehensive geriatric assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/24/5512?source=related_link\">",
"      Consent in adolescent health care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/35/10805?source=related_link\">",
"      Controversies in control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/60/36810?source=related_link\">",
"      Estimation of cardiac risk prior to noncardiac surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/8/1162?source=related_link\">",
"      Evaluation of preoperative pulmonary risk",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/61/15322?source=related_link\">",
"      Hospital management of older adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/5/43094?source=related_link\">",
"      Informed consent",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/11/30905?source=related_link\">",
"      Management of an adnexal mass",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/50/35626?source=related_link\">",
"      Management of anticoagulation before and after elective surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/18/43305?source=related_link\">",
"      Management of hemorrhage in gynecologic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/7/15482?source=related_link\">",
"      Management of pregnant women undergoing nonobstetric surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/47/36601?source=related_link\">",
"      Medical management of the dialysis patient undergoing surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/3/3129?source=related_link\">",
"      Nerve injury associated with pelvic surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/37/33369?source=related_link\">",
"      Operating room safety",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/35/31290?source=related_link\">",
"      Overview of control measures to prevent surgical site infection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/2/19498?source=related_link\">",
"      Overview of pregnancy termination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/48/43786?source=related_link\">",
"      Overview of the causes of venous thrombosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/48/41735?source=related_link\">",
"      Overview of the principles of medical consultation and perioperative medicine",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?29/52/30530?source=related_link\">",
"      Patient information: Questions to ask if you are having a procedure or surgery (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/1/20499?source=related_link\">",
"      Pelvic examination under anesthesia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/9/10394?source=related_link\">",
"      Perioperative care of the surgical patient with neurologic disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/63/29688?source=related_link\">",
"      Perioperative management of diabetes mellitus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/17/33046?source=related_link\">",
"      Perioperative management of hypertension",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/45/40666?source=related_link\">",
"      Perioperative medication management",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/4/10314?source=related_link\">",
"      Preoperative medical evaluation of the healthy patient",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/52/41802?source=related_link\">",
"      Prevention of venous thromboembolic disease in surgical patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/51/13113?source=related_link\">",
"      Strategies to reduce postoperative pulmonary complications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/23/16762?source=related_link\">",
"      Surgical oncologic principles for the resection of colon cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/29/35288?source=related_link\">",
"      Surgical risk and the preoperative evaluation and management of adults with obstructive sleep apnea",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/46/10986?source=related_link\">",
"      The approach to the patient who refuses blood transfusion",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/43/42681?source=related_link\">",
"      The gynecologic history and pelvic examination",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/62/17384?source=related_link\">",
"      The surgical patient taking glucocorticoids",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_55_39801="Eclampsia";
var content_f38_55_39801=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Eclampsia",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/55/39801/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/55/39801/contributors\">",
"     Errol R Norwitz, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/55/39801/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/55/39801/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?38/55/39801/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?38/55/39801/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?38/55/39801/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eclampsia refers to the occurrence of one or more generalized convulsions",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    coma in the setting of preeclampsia and in the absence of other neurologic conditions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/1\">",
"     1",
"    </a>",
"    ]. The clinical manifestations can appear anytime from the second trimester to the puerperium. In the past, eclampsia was thought to be the end result of preeclampsia (hence the nomenclature); however, it is now clear that seizures should be considered merely one of several clinical manifestations of severe preeclampsia (",
"    <a class=\"graphic graphic_table graphicRef76975 \" href=\"mobipreview.htm?42/60/43979\">",
"     table 1",
"    </a>",
"    ), rather than a separate disease. Despite advances in detection and management,",
"    <span class=\"nowrap\">",
"     preeclampsia/eclampsia",
"    </span>",
"    remains a common cause of maternal death [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diagnosis and management of eclampsia will be reviewed here. Issues related to preeclampsia are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34777?source=see_link\">",
"     \"Pathogenesis of preeclampsia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/20/27978?source=see_link\">",
"     \"Preeclampsia: Clinical features and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21882?source=see_link\">",
"     \"Preeclampsia: Management and prognosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/40/41609?source=see_link\">",
"     \"Prevention of preeclampsia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INCIDENCE AND EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;An eclamptic seizure occurs in 2 to 3 percent of severely preeclamptic women not receiving anti-seizure prophylaxis; the seizure rate is estimated to be between 0 and 0.6 percent in women with mild preeclampsia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/3\">",
"     3",
"    </a>",
"    ]. The incidence of eclampsia has been relatively stable at 1.6 to 10 cases per 10,000 deliveries in developed countries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/4-8\">",
"     4-8",
"    </a>",
"    ]. In developing countries, however, the incidence varies widely: from 6 to 157 cases per 10,000 deliveries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/9-11\">",
"     9-11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for eclampsia are similar to those for preeclampsia (",
"    <a class=\"graphic graphic_table graphicRef61266 \" href=\"mobipreview.htm?43/39/44667\">",
"     table 2",
"    </a>",
"    ). Nonwhite, nulliparous women from lower socioeconomic backgrounds are the group at highest risk of developing eclampsia. Peak incidence is in the teenage years and low twenties, but there is also an increased incidence in women over 35 years of age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Timing: antepartum, intrapartum, postpartum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eclampsia prior to 20 weeks of gestation is rare and should raise the possibility of an underlying molar pregnancy or antiphospholipid syndrome. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/11/24761?source=see_link\">",
"     \"Gestational trophoblastic disease: Epidemiology, clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/2/41000?source=see_link\">",
"     \"Obstetrical manifestations of the antiphospholipid syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Approximately one-half of all cases of eclampsia occur prior to term, with more than one-fifth occurring before 31 weeks of gestation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/4\">",
"     4",
"    </a>",
"    ]. Just over one-third of cases occur at term, developing intrapartum or within 48 hours of delivery. Late postpartum eclampsia (ie, eclamptic seizures developing greater than 48 hours, but less than four weeks postpartum) accounts for the remainder (13 to 16 percent) and represents as many as one-quarter of all postpartum cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/12-14\">",
"     12-14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Looked at in another way, the timing and frequency of eclampsia is antepartum (38 to 55 percent), intrapartum (13 to 36 percent), less than or equal to 48 hours postpartum (5 to 39 percent), and greater than 48 hours postpartum (5 to 17 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/5,15\">",
"     5,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A large retrospective cohort study of 152 patients discharged from the hospital postpartum and then readmitted with",
"    <span class=\"nowrap\">",
"     preeclampsia/eclampsia",
"    </span>",
"    more than two days and less than six weeks after delivery observed the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/16\">",
"     16",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      63 percent of the women had no diagnosis of any hypertensive disease during the antecedent pregnancy.",
"     </li>",
"     <li>",
"      14.5 percent of these patients developed eclampsia. Over 90 percent of the cases of eclampsia occurred within seven days of delivery.",
"     </li>",
"     <li>",
"      The most common presenting symptom was headache, which occurred in about 70 percent of patients. Other prodromal symptoms included shortness of breath, blurry vision, nausea or vomiting, edema, neurological deficit, and epigastric pain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOGENESIS OF SEIZURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The exact cause of seizures in women with eclampsia is not known. The following two hypotheses have been proposed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/17\">",
"     17",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cerebral overregulation in response to high systemic blood pressure results in vasospasm of cerebral arteries, underperfusion of the brain, localized",
"      <span class=\"nowrap\">",
"       ischemia/infarction,",
"      </span>",
"      and cytotoxic (intracellular) edema. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/56/24458?source=see_link&amp;anchor=H6#H6\">",
"       \"Cerebrovascular disorders complicating pregnancy\", section on 'Postpartum angiopathy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Loss of autoregulation of cerebral blood flow in response to high systemic pressure (ie, hypertensive encephalopathy) results in hyperperfusion, endothelial damage, and vasogenic (extracellular) edema. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/16/43273?source=see_link&amp;anchor=H11#H11\">",
"       \"Reversible posterior leukoencephalopathy syndrome\", section on 'Eclampsia'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A classic report of autopsies performed shortly after death of eclamptic women described the neurological findings in eclamptic women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/18\">",
"     18",
"    </a>",
"    ]. The brains of more than 50 percent of the women who died within two days of seizures displayed cerebral hemorrhages. Petechial cortical hemorrhages were most common, especially involving the occipital lobe. Diffuse cerebral edema and gross hemorrhage were noted less frequently. Cerebral venous thrombosis was common in women with postpartum eclampsia.",
"   </p>",
"   <p>",
"    Additional findings were observed in the largest magnetic resonance imaging study of eclampsia, which involved 27 nulliparous eclamptic women without neurologic deficit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/19\">",
"     19",
"    </a>",
"    ]. Twenty-five of these women had evidence of cerebral edema, typically involving the subcortical white and adjacent gray matter in the parieto-occipital lobes. Six women had restricted diffusion suggestive of infarction and five of the six had persistent imaging abnormalities six to eight weeks later, but their neurologic examinations remained normal. The authors hypothesized that hypertensive encephalopathy with hyperperfusion, vasogenic edema, and endothelial damage caused the eclamptic seizures and that progressive edema, rather than vasospasm, led to focal areas of cerebral hypoperfusion and, ultimately, infarction in the most severe cases.",
"   </p>",
"   <p>",
"    The pathogenesis of preeclampsia is reviewed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34777?source=see_link\">",
"     \"Pathogenesis of preeclampsia\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Maternal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eclampsia is a clinical diagnosis based upon evidence of one or more generalized convulsions",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    coma in a preeclamptic woman and in the absence of other neurologic conditions. Eclamptic seizures are almost always self-limiting and seldom last longer than three to four minutes (usual duration 60 to 75 seconds). Characteristics of generalized, tonic-clonic seizures are listed in the table (",
"    <a class=\"graphic graphic_table graphicRef54942 \" href=\"mobipreview.htm?13/61/14300\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Symptoms that may occur in the hours before the seizure include persistent frontal or occipital headache, visual disturbances (scotomata, amaurosis fugax, blurred vision, diplopia, homonymous hemianopsia), right upper quadrant or epigastric pain, and altered mental status [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The relationship between the level of blood pressure elevation and onset of seizures is unclear. The diagnosis of preeclampsia may not be suspected prior to the development of seizures in women with relative hypertension (ie, blood pressure elevated compared with patient's baseline, but less than",
"    <span class=\"nowrap\">",
"     140/90",
"    </span>",
"    mmHg) and no proteinuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/4,20,21\">",
"     4,20,21",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H25\">",
"     'Can eclampsia be predicted?'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    In general, women with typical eclamptic seizures who do not have focal neurologic deficits or prolonged coma do not require diagnostic evaluation with either electroencephalographic or cerebral imaging studies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/22\">",
"     22",
"    </a>",
"    ]. If cerebral imaging is performed, magnetic resonance imaging is the optimal study.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Fetal",
"    </span>",
"    &nbsp;&mdash;&nbsp;Fetal bradycardia lasting at least three to five minutes is a common finding during and immediately after an eclamptic seizure, and does not necessitate emergent cesarean delivery. Stabilizing the mother by administering anticonvulsant drugs and oxygen and treating severe hypertension (if present) can help the fetus recover in-utero from the effects of maternal hypoxia, hypercarbia, and uterine tachysystole.",
"   </p>",
"   <p>",
"    Resolution of maternal seizure activity is associated with compensatory fetal tachycardia and loss of variability, sometimes associated with transient fetal heart rate decelerations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/23\">",
"     23",
"    </a>",
"    ]. If the fetal heart rate tracing remains nonreassuring for more than 10 to 15 minutes with no improvement despite maternal and fetal resuscitative interventions, then the possibility of occult abruption and emergent delivery should be considered [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eclamptic seizures are clinically and electroencephalographically indistinguishable from other generalized tonic-clonic seizures. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?27/13/27863?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical neurophysiology\", section on 'Electroencephalogram'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinical conditions other than eclampsia that should be considered when evaluating a pregnant woman who has had a seizure include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Reversible posterior leukoencephalopathy syndrome (RPLS), which consists of headaches, seizures, confusion, and visual disturbances with characteristic neuroimaging findings, is a common clinical syndrome resulting from a number of different causes that are grouped together because of similar findings on neuroimaging. Hypertension is usually, but not invariably, present. Some experts suggest that RPLS is an indicator of eclampsia, even when other features of eclampsia (hypertension, proteinuria) are not present [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/24,25\">",
"       24,25",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Blood pressures in pregnant patients who develop RPLS are generally lower than in patients who develop RPLS in other settings [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/26,27\">",
"       26,27",
"      </a>",
"      ]. The headache is typically constant, nonlocalized, moderate to severe, and unresponsive to analgesia, but may be of sudden onset (thunderclap headache). The pathogenesis of RPLS is unclear, but appears to be related to disordered cerebral autoregulation and endothelial dysfunction. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/16/43273?source=see_link\">",
"       \"Reversible posterior leukoencephalopathy syndrome\"",
"      </a>",
"      .) &nbsp;",
"     </li>",
"     <li>",
"      Stroke (hemorrhage, arterial or venous thrombosis). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?27/47/28410?source=see_link\">",
"       \"Overview of the evaluation of stroke\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/56/24458?source=see_link\">",
"       \"Cerebrovascular disorders complicating pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Hypertensive disease (hypertensive encephalopathy, pheochromocytoma). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?28/28/29130?source=see_link\">",
"       \"Spontaneous intracerebral hemorrhage: Pathogenesis, clinical features, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Space-occupying lesions of the central nervous system (brain tumor, abscess). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?25/3/25657?source=see_link\">",
"       \"Clinical presentation and diagnosis of brain tumors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Metabolic disorders (hypoglycemia, uremia, inappropriate antidiuretic hormone secretion resulting in water intoxication). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/58/23464?source=see_link\">",
"       \"Manifestations of hyponatremia and hypernatremia\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?43/39/44664?source=see_link\">",
"       \"Hypoglycemia in adults: Clinical manifestations, definition, and causes\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infection (meningitis, encephalitis). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?38/3/38968?source=see_link\">",
"       \"Viral encephalitis in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=see_link\">",
"       \"Clinical features and diagnosis of acute bacterial meningitis in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Thrombotic thrombocytopenic purpura or thrombophilia. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/1/29721?source=see_link\">",
"       \"Diagnosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/5/26714?source=see_link\">",
"       \"Inherited thrombophilias in pregnancy\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/56/24458?source=see_link\">",
"       \"Cerebrovascular disorders complicating pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Idiopathic epilepsy. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?22/6/22633?source=see_link\">",
"       \"Risks associated with epilepsy and pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Use of illicit drugs (eg, methamphetamine, cocaine).",
"     </li>",
"     <li>",
"      Cerebral vasculitis. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/50/25386?source=see_link\">",
"       \"Primary angiitis of the central nervous system\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?23/56/24458?source=see_link\">",
"       \"Cerebrovascular disorders complicating pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These etiologies are particularly important in pregnant women who seize in the first half of pregnancy when eclampsia is rare and in those with focal neurologic deficits, prolonged coma, or atypical eclampsia. The approach to evaluation and treatment of noneclamptic seizures is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25753?source=see_link\">",
"     \"Evaluation of the first seizure in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of management strategies have been developed to prevent maternal and fetal complications resulting from eclampsia during the peripartum period.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     General principles",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the seizure is witnessed, maintenance of airway patency and prevention of aspiration should be the first responsibilities of management. The gravida should be rolled onto her left side. A bed with raised, padded side rails provides protection from trauma. Supplemental oxygen (8 to 10",
"    <span class=\"nowrap\">",
"     L/min)",
"    </span>",
"    via a face mask has been recommended to treat hypoxemia due to hypoventilation during the convulsive episode [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The immediate issues in caring for an eclamptic woman include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Prevention of maternal hypoxia and trauma",
"     </li>",
"     <li>",
"      Management of severe hypertension, if present",
"     </li>",
"     <li>",
"      Prevention of recurrent seizures",
"     </li>",
"     <li>",
"      Evaluation for prompt delivery.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The definitive treatment of eclampsia is delivery, irrespective of gestational age, to reduce the risk of maternal morbidity and mortality from complications of the disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Treatment of hypertension",
"    </span>",
"    &nbsp;&mdash;&nbsp;Strokes account for 15 to 20 percent of deaths from eclampsia. The general risk of stroke in the nonpregnant population correlates directly with the degree of elevation in systolic and diastolic pressures and age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/28\">",
"     28",
"    </a>",
"    ]. It is not clear whether there is a threshold pressure above which emergent therapy should be instituted in pregnant hypertensive women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/29\">",
"     29",
"    </a>",
"    ]. Most experts recommend aggressive antihypertensive therapy for sustained diastolic pressures greater than 105 to 110 mmHg or systolic blood pressures greater than or equal to 160 mmHg [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/30\">",
"     30",
"    </a>",
"    ], although the validity of thresholds has not been tested prospectively. The cerebral vasculature of women with underlying chronic hypertension can probably tolerate higher systolic pressures without injury, while adolescents with normally low blood pressures may benefit from starting treatment at lower blood pressure levels. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13434?source=see_link\">",
"     \"Management of hypertension in pregnant and postpartum women\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Options for initial treatment include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?14/57/15254?source=see_link\">",
"       Hydralazine",
"      </a>",
"      beginning with 5 mg intravenously, followed by 5 to 10 mg boluses as necessary every 20 minutes",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35544?source=see_link\">",
"       Labetalol",
"      </a>",
"      beginning with 10 or 20 mg intravenously followed by doubling the dose at 10-minute intervals up to 80 mg for a maximum total cumulative dose of 220 to 230 mg (eg, 20-40-80-80 mg or 10-20-40-80-80 mg), or",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Although clinical trials have not adequately addressed the question of how aggressively to lower an eclamptic patient's blood pressure, many experts consider a reasonable goal to be a systolic pressure of 140 to 155 mmHg and diastolic pressure of 90 to 105 mmHg. In women with extremely severe hypertension",
"    <span class=\"nowrap\">",
"     (&ge;180/120",
"    </span>",
"    mmHg), a diastolic goal of 100 to 105 mmHg should be achieved within two to six hours, with the maximum initial (within 10 to 20 minutes) fall in BP not exceeding 25 percent of the presenting value [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. An additional therapeutic option in these women is",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?41/61/42969?source=see_link\">",
"     nicardipine",
"    </a>",
"    beginning with 5",
"    <span class=\"nowrap\">",
"     mg/hour",
"    </span>",
"    intravenously and increased by 2.5",
"    <span class=\"nowrap\">",
"     mg/hour",
"    </span>",
"    every 5 to 15 minutes to a maximum dose of 15",
"    <span class=\"nowrap\">",
"     mg/hour.",
"    </span>",
"    Data supporting this recommendation are provided separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13434?source=see_link\">",
"     \"Management of hypertension in pregnant and postpartum women\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/27/41398?source=see_link\">",
"     \"Malignant hypertension and hypertensive encephalopathy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Women who do not improve rapidly following control of seizures and hypertension, or those who develop localizing neurologic signs, should be evaluated further. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25753?source=see_link\">",
"     \"Evaluation of the first seizure in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The use of antihypertensive agents to control mildly elevated blood pressure in the setting of",
"    <span class=\"nowrap\">",
"     preeclampsia/eclampsia",
"    </span>",
"    has not been shown to alter the course of the disease, nor to diminish perinatal morbidity or mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/33-35\">",
"     33-35",
"    </a>",
"    ]. Pharmacologic treatment of mild hypertension is not recommended, as neither maternal nor fetal benefits have been demonstrated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Treatment of convulsions",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial convulsion is usually of short duration and often occurs in a setting where intravenous access and drugs are not readily available. Therefore, treatment is primarily directed at prevention of recurrent convulsions rather than control of the initial seizure. The drug of choice is",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    .",
"   </p>",
"   <p>",
"    An additional benefit of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    therapy is that randomized placebo-controlled trials of maternal administration of magnesium sulfate in women expected to have a preterm delivery within 24 hours have consistently demonstrated a decreased risk of cerebral palsy and severe motor dysfunction in offspring. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/49/43799?source=see_link\">",
"     \"Neuroprotective effects of in utero exposure to magnesium sulfate\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Prevention of recurrent convulsions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 10 percent of eclamptic women will have repeated seizures if managed expectantly [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/36\">",
"     36",
"    </a>",
"    ]. There is universal agreement that women with eclampsia require anticonvulsant therapy to prevent further seizures and the possible complications of repeated seizure activity: neuronal death, rhabdomyolysis, metabolic acidosis, aspiration pneumonitis, neurogenic pulmonary edema, and respiratory failure. However, the choice of agent has been controversial. Obstetricians favor",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    as the drug of choice for prevention of recurrent eclamptic seizures, whereas neurologists tend to favor anticonvulsants traditionally used in nonpregnant individuals, such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    . The following evidence appears to have resolved this dispute in favor of magnesium sulfate:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The Eclampsia Trial Collaborative Group conducted two prospective trials in which 905 eclamptic women were randomly assigned to receive either magnesium or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"       diazepam",
"      </a>",
"      and another 775 eclamptic women were randomly assigned to receive either magnesium or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/37\">",
"       37",
"      </a>",
"      ]. The primary outcome measures were the rates of recurrent seizures and maternal death.",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"       Magnesium sulfate",
"      </a>",
"      was significantly more effective than either diazepam or phenytoin:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Women allocated to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"       magnesium sulfate",
"      </a>",
"      therapy had one-half the rate of recurrent convulsions of those allocated to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"       diazepam",
"      </a>",
"      (13 and 28 percent, respectively). There were no other significant differences in maternal or perinatal mortality",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      morbidity between the two groups.",
"     </li>",
"     <li>",
"      Women allocated to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"       magnesium sulfate",
"      </a>",
"      had one-third the rate of recurrent convulsions of those allocated to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      (6 versus 17 percent). In this arm of the study, women who received magnesium were less likely to be admitted to an intensive care facility (17 versus 25 percent), less likely to require ventilatory support (15 versus 23 percent), and less likely to develop pneumonia (4 versus 9 percent) compared with women who were given phenytoin. There were no other significant differences in maternal mortality or perinatal outcome between the two groups.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A series of systematic reviews reported",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"       magnesium sulfate",
"      </a>",
"      was safer and more effective than",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"       diazepam",
"      </a>",
"      , or lytic cocktail (ie,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?29/38/30312?source=see_link\">",
"       chlorpromazine",
"      </a>",
"      ,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/20/15688?source=see_link\">",
"       promethazine",
"      </a>",
"      and pethidine) for prevention of repeat seizures in eclamptic women [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/38-40\">",
"       38-40",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    In summary, randomized controlled trials of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    for prevention of recurrent seizures in women with eclampsia have demonstrated this drug can reduce the rate of recurrent seizures by one-half to two-thirds (RR 0.44, 95% CI 0.32-0.51) and can reduce the rate of maternal death by one-third (RR 0.62, 95% CI 0.39-0.99) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Additional advantages of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    therapy include lower cost, ease of administration (eg, cardiac monitoring is not required), and less sedation than either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    . Magnesium also appears to selectively increase cerebral blood flow and oxygen consumption in women with preeclampsia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/41\">",
"     41",
"    </a>",
"    ]; this is not true for phenytoin [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/42\">",
"     42",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Administration of magnesium sulfate",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    recommended by experts varies from 4 to 6 g intravenously over 15 to 20 minutes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/43\">",
"     43",
"    </a>",
"    ]. We use 6 g. This dose will achieve resolution of an ongoing convulsion and provide the loading dose prior to maintenance therapy for prevention of recurrences. An alternative",
"    <span class=\"nowrap\">",
"     dose/route",
"    </span>",
"    is magnesium sulfate 5 g intramuscularly into each buttock; however, the onset of a therapeutic effect will be slower and intramuscular injection is painful.",
"   </p>",
"   <p>",
"    These doses may be given safely even in the presence of renal insufficiency. Concurrent use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    with calcium channel blockers may result in hypotension. Magnesium sulfate is contraindicated in women with myasthenia gravis since it can precipitate a severe myasthenic crisis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36567?source=see_link&amp;anchor=H8#H8\">",
"     \"Management of myasthenia gravis in pregnancy\", section on 'Treatment issues'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The maintenance dose of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    after the initial 6 g loading dose is 1 to 3",
"    <span class=\"nowrap\">",
"     g/hour",
"    </span>",
"    administered as a continuous intravenous infusion, we use 2",
"    <span class=\"nowrap\">",
"     g/hour;",
"    </span>",
"    alternatively, 5 g can be given intramuscularly every four hours, but this is painful. The maintenance phase is given only if a patellar reflex is present (loss of deep tendon reflexes is the first manifestation of symptomatic hypermagnesemia), respirations are greater than 12 per minute, and urine output is over 100 mL in four hours.",
"   </p>",
"   <p>",
"    Following serum magnesium levels is not required if the woman's clinical status is closely monitored for evidence of potential magnesium toxicity. There does not appear to be a clear threshold magnesium concentration for insuring the prevention of convulsions, although a range of 4.8 to 8.4",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    has been recommended [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/44\">",
"     44",
"    </a>",
"    ]. The dose should be adjusted according to the clinical response of individual patients.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?18/11/18616?source=see_link\">",
"     Calcium gluconate",
"    </a>",
"    (1 g intravenously) may be administered to counteract magnesium toxicity, if necessary.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     Management of persistent convulsions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent convulsions occurring in patients on maintenance",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    therapy can be treated with an additional bolus of 2 grams of magnesium sulfate over 15 to 20 minutes, with careful monitoring for signs of magnesium toxicity (see above). If two such boluses do not control seizures, then other measures should be instituted. A number of options are included below, although",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"     diazepam",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    are used most commonly.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"       Diazepam",
"      </a>",
"      &mdash; Intravenously administered diazepam (0.1 to 0.3",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      over 60 seconds, maximum cumulative dose 20 mg) rapidly enters the central nervous system, where it achieves anticonvulsant levels within one minute, and will control seizures in greater than 80 percent of patients within five minutes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/45\">",
"       45",
"      </a>",
"      ]. A diazepam gel for rectal administration is also available (0.2",
"      <span class=\"nowrap\">",
"       mg/kg).",
"      </span>",
"      Some experts recommend avoiding benzodiazepines for management of eclamptic seizures because of potentially profound depressant effects on the fetus and mother. This effect becomes clinically significant when the total maternal dose of diazepam exceeds 30 mg. Because of subsequent redistribution of the drug into adipose tissue, the duration of diazepam's acute anticonvulsant effect is typically less than 20 minutes.",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?8/8/8329?source=see_link\">",
"       Lorazepam",
"      </a>",
"      0.02 to 0.03",
"      <span class=\"nowrap\">",
"       mg/kg",
"      </span>",
"      intravenously, allowing approximately one minute to assess its effect. If seizures continue at this point, additional doses of lorazepam (up to a cumulative dose of 0.1",
"      <span class=\"nowrap\">",
"       mg/kg)",
"      </span>",
"      are infused at a maximum rate of 2",
"      <span class=\"nowrap\">",
"       mg/minute",
"      </span>",
"      for acute treatment. Lorazepam is as effective as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"       diazepam",
"      </a>",
"      in terminating seizures, but the time from its injection to its maximum effect against seizures is as long as two minutes. The clinical advantage of lorazepam is that the effective duration of action against seizures is as long as four to six hours because of its less pronounced redistribution into adipose tissue.",
"     </li>",
"     <li>",
"      <strong>",
"       Sodium",
"      </strong>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?36/7/36982?source=see_link\">",
"       amobarbital",
"      </a>",
"      250 mg intravenously over three to five minutes [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/15\">",
"       15",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Treatment of status epilepticus is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/11/19642?source=see_link\">",
"     \"Status epilepticus in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Delivery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Eclampsia is usually considered an absolute contraindication to expectant management, although this has been attempted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/46\">",
"     46",
"    </a>",
"    ]. The definitive treatment for eclampsia is prompt delivery; however, this does not necessarily preclude induction of labor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/47,48\">",
"     47,48",
"    </a>",
"    ]. After maternal stabilization, factors to consider in determining the mode of delivery are gestational age, Bishop score, whether the patient is in labor, and fetal condition and position.",
"   </p>",
"   <p>",
"    We feel that induction is a reasonable option for women with a favorable cervix at any gestational age or who are greater than 32 to 34 weeks of gestation. Cervical ripening agents can be used to improve the Bishop score; however, in our opinion, long inductions should be avoided and a clear endpoint for delivery planned (eg, within 24 hours). In a trial in rural India that randomly assigned 200 eclamptic women at &ge;34 weeks to cesarean delivery after initial stabilization or to induction, planned cesarean delivery did not lead to a statistically significant reduction in adverse maternal or fetal events, and almost three-quarters of women in the planned vaginal delivery group delivered vaginally [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/49\">",
"     49",
"    </a>",
"    ]. This trial provides support for induction of labor, although it had several limitations: the number of events was small, leading to wide confidence intervals, and the population is not representative of women and intrapartum care in a higher resource setting. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?30/37/31322?source=see_link\">",
"     \"Principles of labor induction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In contrast, we would not induce eclamptic women at less than 32 to 34 weeks of gestation with an unfavorable cervix. In US studies, fewer than one-third of these women successfully delivered vaginally [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/36,50,51\">",
"     36,50,51",
"    </a>",
"    ]. Cesarean delivery is a reasonable option for these women. Because the fetus benefits from in utero resuscitation before delivery, it is desirable to wait 15 to 20 minutes and until the mother and fetus show signs of recovery (control of convulsions; mother oriented to name, time, and place; fetal heart rate reassuring) before proceeding to surgery, if possible.",
"   </p>",
"   <p>",
"    Anesthesia issues are the same as for women with preeclampsia. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21882?source=see_link&amp;anchor=H704577#H704577\">",
"     \"Preeclampsia: Management and prognosis\", section on 'Anesthesia'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no role for",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?3/42/3752?source=see_link\">",
"     mannitol",
"    </a>",
"    in the routine care of women with eclampsia. It can be harmful because it can enter the brain through a damaged blood-brain barrier and reverse the osmotic gradient, thus increasing intracranial pressure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     POSTPARTUM COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maternal vital signs, input, and output should be monitored closely to detect large changes in blood pressure and fluid imbalance. Seizures due to eclampsia always resolve postpartum, generally within a few hours to days. Diuresis (greater than 4",
"    <span class=\"nowrap\">",
"     L/day)",
"    </span>",
"    is believed to be the most accurate clinical indicator of resolution of",
"    <span class=\"nowrap\">",
"     preeclampsia/eclampsia,",
"    </span>",
"    but is not a guarantee against the development of seizures [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Anticonvulsant drugs are generally administered for 24 to 48 hours postpartum, when the risk of recurrent seizures is low. The optimal duration of therapy has not been determined. Therapy is continued in women whose disease has not begun to improve postpartum and discontinued in women who are clearly improving clinically (eg, diuresis of &ge;100",
"    <span class=\"nowrap\">",
"     mL/h",
"    </span>",
"    for two consecutive hours and the absence of symptoms). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21882?source=see_link&amp;anchor=H22#H22\">",
"     \"Preeclampsia: Management and prognosis\", section on 'Magnesium regimen and monitoring'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For women receiving",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"     magnesium sulfate",
"    </a>",
"    prophylaxis postpartum, decisions regarding activity, oral intake, and infant care should be made on a case-by-case basis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A summary of the type and frequency of complications of eclampsia is shown in the table (",
"    <a class=\"graphic graphic_table graphicRef70241 \" href=\"mobipreview.htm?21/50/22315\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Maternal outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Maternal complications occur in up to 70 percent of women with eclampsia and include abruption placentae, disseminated intravascular coagulopathy, acute renal failure, hepatocellular injury, liver rupture, intracerebral hemorrhage, transient blindness, cardiorespiratory arrest, aspiration pneumonitis, acute pulmonary edema, and postpartum hemorrhage [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/36\">",
"     36",
"    </a>",
"    ]. Hepatocellular damage, renal dysfunction, coagulopathy, hypertension, and neurologic abnormalities typically resolve following delivery. However, brain damage from hemorrhage or ischemia may result in permanent neurologic sequelae and is the most common cause of death in eclamptic women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/52,53\">",
"     52,53",
"    </a>",
"    ]. HELLP syndrome (Hemolysis, Elevated Liver enzymes, Low Platelets) develops in approximately 10 to 20 percent of women with",
"    <span class=\"nowrap\">",
"     preeclampsia/eclampsia.",
"    </span>",
"   </p>",
"   <p>",
"    Maternal",
"    mortality rates of 0 to 14 percent have been reported over the past few decades [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/4,6,20,54\">",
"     4,6,20,54",
"    </a>",
"    ]. Maternal mortality and severe morbidity rates are lowest among women receiving regular prenatal care who are managed by experienced physicians in tertiary centers (maternal mortality 0 to 1.8 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/6,15,21,36,55,56\">",
"     6,15,21,36,55,56",
"    </a>",
"    ]. The highest rates are in developing countries where prenatal, intrapartum, and neonatal care are compromised by limited resources [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/54,57\">",
"     54,57",
"    </a>",
"    ]. These relationships are illustrated by the following large series:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A population-based cohort study from Canada including 1481 cases of eclampsia from 2003 to 2009 reported a case mortality rate of 0.34 percent",
"      <span class=\"nowrap\">",
"       (5/1481)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/7\">",
"       7",
"      </a>",
"      ]. Severe morbidity included acute renal failure, need for assisted ventilation, embolism, shock, and adult respiratory distress syndrome.",
"     </li>",
"     <li>",
"      A retrospective analysis of 990 cases of eclampsia in Mexico before 1992 reported a case mortality rate of 13.9 percent",
"      <span class=\"nowrap\">",
"       (138/990)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/54\">",
"       54",
"      </a>",
"      ]. The subgroup of women with eclampsia prior to 28 weeks of gestation had the highest risk of maternal death",
"      <span class=\"nowrap\">",
"       (12/54",
"      </span>",
"      or 22 percent); multiple seizures outside of the hospital setting was another common cause of death.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Perinatal outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Premature delivery, abruptio placenta, and intrauterine asphyxia are the primary causes of perinatal death in eclamptic pregnancies. Perinatal mortality ranges from 2 to 23 percent and is closely related to gestational age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/4,7,54\">",
"     4,7,54",
"    </a>",
"    ]. As an example, perinatal mortality in a series of 54 pregnant women with eclampsia prior to 28 weeks of gestation was 93 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/54\">",
"     54",
"    </a>",
"    ], but only 9 percent in another study in which the mean gestational age at birth was 32 weeks [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Perinatal morbidity is also closely related to gestational age. In addition, there is a two- to three-fold increased risk of delivery of a small for gestational age infant [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h2\">",
"     Recurrence risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;Recurrent eclampsia occurs in 2 percent of subsequent pregnancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/59,60\">",
"     59,60",
"    </a>",
"    ]. The risk appears to be reduced by close maternal monitoring and timely intervention if preeclampsia develops [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/61\">",
"     61",
"    </a>",
"    ]. Preeclampsia, however, cannot be prevented. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/40/41609?source=see_link\">",
"     \"Prevention of preeclampsia\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk of recurrence was illustrated by a study that followed 159 nulliparous women with a history of eclampsia and no preexisting hypertension through 334 subsequent pregnancies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/62\">",
"     62",
"    </a>",
"    ]. The incidence of mild preeclampsia, severe preeclampsia, and eclampsia in these pregnancies was 13, 9, and 2 percent, respectively. The corresponding figures for the subset of women whose eclampsia occurred at &le;30 weeks of gestation in the index pregnancy were 17, 25, and 2 percent, respectively.",
"   </p>",
"   <p>",
"    Subsequent pregnancies in women with a history of severe preeclampsia or eclampsia are also at increased risk of other obstetric complications compared to women with no such history. These problems include [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/59,60,62,63\">",
"     59,60,62,63",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abruptio placenta (2.5 to 6.5 versus 0.4 to 1.3 percent of the general obstetrical population)",
"     </li>",
"     <li>",
"      Preterm delivery (15 to 21 versus 12 percent)",
"     </li>",
"     <li>",
"      Intrauterine growth restriction (12 to 23 versus 10 percent)",
"     </li>",
"     <li>",
"      Perinatal mortality (4.6 to 16.5 versus 1 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Women with a history of",
"    <span class=\"nowrap\">",
"     preeclampsia/eclampsia",
"    </span>",
"    remote from term (less than 28 weeks of gestation) are at highest risk of developing these complications, as well as recurrent preeclampsia [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/62,63\">",
"     62,63",
"    </a>",
"    ]. This risk appears to be the same whether they had severe preeclampsia or eclampsia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Long-term maternal prognosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic hypertension develops in 0 to 78 percent (mean 24 percent) of women with a history of",
"    <span class=\"nowrap\">",
"     preeclampsia/eclampsia",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/59,60,62-64\">",
"     59,60,62-64",
"    </a>",
"    ]. The wide range reported in the literature is due to the influence of variables such as maternal age and duration of follow-up (the increased risk of subsequent hypertension only becomes apparent after an average follow-up of 10 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/60\">",
"     60",
"    </a>",
"    ]). The risk appears to be highest in the subgroup of women who have subsequent hypertensive pregnancies, multiparas with eclampsia, and those with eclampsia remote from term [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/59,60,62\">",
"     59,60,62",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a study of 39 women with a history of eclampsia, magnetic resonance imaging performed an average of 6.4 years following the index pregnancy showed these women had a higher prevalence of white matter lesions than matched controls with normotensive uncomplicated pregnancies (OR 3.3, 95% CI 1.05-10.6) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/65\">",
"     65",
"    </a>",
"    ]. About 15 percent of women in each group were currently hypertensive or on antihypertensive therapy. The source and significance of these lesions are unclear; affected women do not appear to have increased functional impairment as may be seen in other patients with white matter lesion. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/57/37786?source=see_link&amp;anchor=H16#H16\">",
"     \"Etiology, clinical manifestations, and diagnosis of vascular dementia\", section on 'White matter lesions'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other long-term maternal risks are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21882?source=see_link&amp;anchor=H21332929#H21332929\">",
"     \"Preeclampsia: Management and prognosis\", section on 'Prognosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Can eclampsia be predicted?",
"    </span>",
"    &nbsp;&mdash;&nbsp;The relationship between hypertension, signs and symptoms of cortical irritability (eg, headache that is usually severe or persistent, visual disturbances, nausea, vomiting, fever, hyperreflexia), and seizures remains unclear. The magnitude of blood pressure elevation does",
"    <strong>",
"     not",
"    </strong>",
"    appear to be predictive of eclampsia, although it correlates well with the incidence of stroke (",
"    <a class=\"graphic graphic_figure graphicRef66793 \" href=\"mobipreview.htm?12/18/12591\">",
"     figure 1",
"    </a>",
"    ). Twenty to 38 percent of eclamptic patients have a maximal blood pressure less than",
"    <span class=\"nowrap\">",
"     140/90",
"    </span>",
"    prior to their seizure and about 20 percent have no evidence of proteinuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/4,20,21\">",
"     4,20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The majority of eclamptic women have one or more antecedent symptoms in the hours prior to an eclamptic seizure. A retrospective analysis of 383 cases of eclampsia in the United Kingdom reported that 59 percent of eclamptic women experienced prodromal headache, visual disturbance (eg, scotomata, amaurosis, blurred vision, diplopia, homonymous hemianopsia), or epigastric pain [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/4\">",
"     4",
"    </a>",
"    ]. Pregnant women should be aware that they should call their health care provider if these symptoms develop. However, in a literature review, 20 to 40 percent of eclamptic seizures were not preceded by premonitory symptoms.",
"   </p>",
"   <p>",
"    This study also found that eclampsia was the first manifestation of pregnancy-related hypertensive disease in 38 percent of cases [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/4\">",
"     4",
"    </a>",
"    ]. Similar findings were reported in studies from Sweden, Scotland, Tanzania, and the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/66-69\">",
"     66-69",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one review of 179 consecutive cases, factors identified to be at least partially responsible for failure to prevent eclampsia were: physician error (36 percent), lack of prenatal care (19 percent), abrupt onset (18 percent), magnesium failure (13 percent), late postpartum onset (12 percent), and early onset before 21 weeks (3 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?38/55/39801/abstract/67\">",
"     67",
"    </a>",
"    ]. Therefore, many cases of eclampsia do not appear to be preventable, even among women receiving regular prenatal care, or those who are hospitalized.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Prevention of the first eclamptic seizure in preeclamptic women",
"    </span>",
"    &nbsp;&mdash;&nbsp;This topic is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21882?source=see_link&amp;anchor=H16#H16\">",
"     \"Preeclampsia: Management and prognosis\", section on 'Seizure prophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Summary",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Eclampsia refers to the occurrence of one or more generalized convulsions",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      coma in the setting of preeclampsia and in the absence of other neurologic conditions. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An eclamptic seizure occurs in 0.5 percent of mildly preeclamptic women and 2 percent of severely preeclamptic women. The incidence of eclampsia is 4 to 5 cases per 10,000 live births in developed countries. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Incidence and epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Just over one-third of cases occur at term, developing intrapartum or within 48 hours of delivery. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Timing: antepartum, intrapartum, postpartum'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An eclamptic seizure is typically tonic-clonic and lasts 60 to 75 seconds. Symptoms that may occur before the seizure include persistent frontal or occipital headache, blurred vision, photophobia, right upper quadrant or epigastric pain, and altered mental status. In up to one-third of cases, there is no proteinuria or blood pressure is less than",
"      <span class=\"nowrap\">",
"       140/90",
"      </span>",
"      mmHg prior to the seizure. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Clinical manifestations and diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H25\">",
"       'Can eclampsia be predicted?'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The goals of management are to stabilize the mother, prevent recurrent convulsions, treat severe hypertension to prevent cerebral hemorrhage, and initiate delivery of the fetus. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The risk of recurrent eclampsia in a future pregnancy is 2 percent. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Recurrence risk'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Recommendations",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For women with eclampsia, we recommend treatment with",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"       magnesium sulfate",
"      </a>",
"      rather than other anticonvulsants (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). Compared to",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/48/35594?source=see_link\">",
"       phenytoin",
"      </a>",
"      and",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?15/46/16105?source=see_link\">",
"       diazepam",
"      </a>",
"      , magnesium sulfate reduces the rate of recurrent seizures by one-half to two-thirds and reduces the rate of maternal death by one-third. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Treatment of convulsions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Given that intravascular administration has a faster therapeutic effect and is less painful than intramuscular administration, we suggest using an intravascular regimen (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). We give a loading dose of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?26/25/27031?source=see_link\">",
"       magnesium sulfate",
"      </a>",
"      6 g intravenously over 15 minutes, followed by 2",
"      <span class=\"nowrap\">",
"       g/hour",
"      </span>",
"      administered as a continuous intravenous infusion, but loading doses of 4 or 5 g are reasonable and a lower or higher maintenance dose (1 or 3",
"      <span class=\"nowrap\">",
"       g/hour)",
"      </span>",
"      is sometimes required.",
"      <br/>",
"      <br/>",
"      The loading dose may be given safely in the presence of renal insufficiency, but the maintenance dose should be omitted or reduced in this setting. The maintenance phase is given only if a patellar reflex is present (loss of deep tendon reflexes is the first manifestation of symptomatic hypermagnesemia), respirations are greater than 12 per minute, and urine output is over 100 mL in four hours. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Administration of magnesium sulfate'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In women with severe hypertension, we administer",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?14/57/15254?source=see_link\">",
"       hydralazine",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?34/45/35544?source=see_link\">",
"       labetalol",
"      </a>",
"      to achieve a systolic pressure of 140 to 155 mmHg and diastolic pressure of 90 to 105 mmHg. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Treatment of hypertension'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Delivery is the only curative treatment, but this does not necessarily preclude induction of labor. Cesarean delivery is a reasonable option for women less than 32 weeks of gestation who have an unfavorable cervix. After a seizure, we suggest waiting 15 to 20 minutes and until the mother and fetus show signs of recovery (control of convulsions; mother oriented to name, time, and place; fetal heart rate reassuring) before proceeding to surgery, if possible. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Delivery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     American College of Obstetricians and Gynecologists. Hypertension in Pregnancy. ACOG. Technical Bulletin #219. American College of obstetricians and Gynecologists, Washington, DC, 1996.",
"    </li>",
"    <li>",
"     www.CDC.gov.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/3\">",
"      Sibai BM. Magnesium sulfate prophylaxis in preeclampsia: Lessons learned from recent trials. Am J Obstet Gynecol 2004; 190:1520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/4\">",
"      Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ 1994; 309:1395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/5\">",
"      Tuffnell DJ, Jankowicz D, Lindow SW, et al. Outcomes of severe pre-eclampsia/eclampsia in Yorkshire 1999/2003. BJOG 2005; 112:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/6\">",
"      Zwart JJ, Richters A, Ory F, et al. Eclampsia in the Netherlands. Obstet Gynecol 2008; 112:820.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/7\">",
"      Liu S, Joseph KS, Liston RM, et al. Incidence, risk factors, and associated complications of eclampsia. Obstet Gynecol 2011; 118:987.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/8\">",
"      Tan KH, Kwek K, Yeo GS. Epidemiology of pre-eclampsia and eclampsia at the KK Women's and Children's Hospital, Singapore. Singapore Med J 2006; 47:48.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/9\">",
"      Geographic variation in the incidence of hypertension in pregnancy. World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Am J Obstet Gynecol 1988; 158:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/10\">",
"      Eke AC, Ezebialu IU, Okafor C. Presentation and outcome of eclampsia at a tertiary center in South East Nigeria--a 6-year review. Hypertens Pregnancy 2011; 30:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/11\">",
"      Miguil M, Chekairi A. Eclampsia, study of 342 cases. Hypertens Pregnancy 2008; 27:103.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/12\">",
"      Lubarsky SL, Barton JR, Friedman SA, et al. Late postpartum eclampsia revisited. Obstet Gynecol 1994; 83:502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/13\">",
"      Miles JF Jr, Martin JN Jr, Blake PG, et al. Postpartum eclampsia: a recurring perinatal dilemma. Obstet Gynecol 1990; 76:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/14\">",
"      Chames MC, Livingston JC, Ivester TS, et al. Late postpartum eclampsia: a preventable disease? Am J Obstet Gynecol 2002; 186:1174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/15\">",
"      Sibai BM. Diagnosis, prevention, and management of eclampsia. Obstet Gynecol 2005; 105:402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/16\">",
"      Al-Safi Z, Imudia AN, Filetti LC, et al. Delayed postpartum preeclampsia and eclampsia: demographics, clinical course, and complications. Obstet Gynecol 2011; 118:1102.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/17\">",
"      Morriss MC, Twickler DM, Hatab MR, et al. Cerebral blood flow and cranial magnetic resonance imaging in eclampsia and severe preeclampsia. Obstet Gynecol 1997; 89:561.",
"     </a>",
"    </li>",
"    <li>",
"     Sheehan, HL, Lynch, JB. Pathology of toxaemia of pregnancy. William and wilkins, Baltimore, 1973.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/19\">",
"      Zeeman GG, Fleckenstein JL, Twickler DM, Cunningham FG. Cerebral infarction in eclampsia. Am J Obstet Gynecol 2004; 190:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/20\">",
"      Sibai BM, McCubbin JH, Anderson GD, et al. Eclampsia. I. Observations from 67 recent cases. Obstet Gynecol 1981; 58:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/21\">",
"      Sibai BM. Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990; 163:1049.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/22\">",
"      Dahmus MA, Barton JR, Sibai BM. Cerebral imaging in eclampsia: magnetic resonance imaging versus computed tomography. Am J Obstet Gynecol 1992; 167:935.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/23\">",
"      Paul RH, Koh KS, Bernstein SG. Changes in fetal heart rate-uterine contraction patterns associated with eclampsia. Am J Obstet Gynecol 1978; 130:165.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/24\">",
"      Ille O, Woimant F, Pruna A, et al. Hypertensive encephalopathy after bilateral carotid endarterectomy. Stroke 1995; 26:488.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/25\">",
"      Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/26\">",
"      Schwartz RB, Feske SK, Polak JF, et al. Preeclampsia-eclampsia: clinical and neuroradiographic correlates and insights into the pathogenesis of hypertensive encephalopathy. Radiology 2000; 217:371.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/27\">",
"      Wagner SJ, Acquah LA, Lindell EP, et al. Posterior reversible encephalopathy syndrome and eclampsia: pressing the case for more aggressive blood pressure control. Mayo Clin Proc 2011; 86:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/28\">",
"      Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/29\">",
"      Lindenstr&oslash;m E, Boysen G, Nyboe J. Influence of systolic and diastolic blood pressure on stroke risk: a prospective observational study. Am J Epidemiol 1995; 142:1279.",
"     </a>",
"    </li>",
"    <li>",
"     Working group report on high blood pressure in pregnancy. National Institutes of Health, Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/31\">",
"      Vaughan CJ, Delanty N. Hypertensive emergencies. Lancet 2000; 356:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/32\">",
"      Ledingham JG, Rajagopalan B. Cerebral complications in the treatment of accelerated hypertension. Q J Med 1979; 48:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/33\">",
"      Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996; 335:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/34\">",
"      von Dadelszen P, Ornstein MP, Bull SB, et al. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 2000; 355:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/35\">",
"      Magee LA, Ornstein MP, von Dadelszen P. Fortnightly review: management of hypertension in pregnancy. BMJ 1999; 318:1332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/36\">",
"      Pritchard JA, Cunningham FG, Pritchard SA. The Parkland Memorial Hospital protocol for treatment of eclampsia: evaluation of 245 cases. Am J Obstet Gynecol 1984; 148:951.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/37\">",
"      Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345:1455.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/38\">",
"      Duley L, Gulmezoglu AM. Magnesium sulphate versus lytic cocktail for eclampsia. Cochrane Database Syst Rev 2001; :CD002960.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/39\">",
"      Duley L, Henderson-Smart D. Magnesium sulphate versus diazepam for eclampsia. Cochrane Database Syst Rev 2003; :CD000127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/40\">",
"      Duley L, Henderson-Smart D. Magnesium sulphate versus phenytoin for eclampsia. Cochrane Database Syst Rev 2003; :CD000128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/41\">",
"      Belfort MA, Moise KJ Jr. Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol 1992; 167:661.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/42\">",
"      Gerthoffer WT, Shafer PG, Taylor S. Selectivity of phenytoin and dihydropyridine calcium channel blockers for relaxation of the basilar artery. J Cardiovasc Pharmacol 1987; 10:9.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists. Diagnosis and management of preeclampsia and eclampsia. ACOG practice bulletin #33. American College of Obstetricians and Gynecologists, 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/44\">",
"      Sibai BM, Lipshitz J, Anderson GD, Dilts PV Jr. Reassessment of intravenous MgSO4 therapy in preeclampsia-eclampsia. Obstet Gynecol 1981; 57:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/45\">",
"      Delgado-Escueta AV, Wasterlain C, Treiman DM, Porter RJ. Current concepts in neurology: management of status epilepticus. N Engl J Med 1982; 306:1337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/46\">",
"      Andersen WA, Harbert GM Jr. Conservative management of pre-eclamptic and eclamptic patients: a re-evaluation. Am J Obstet Gynecol 1977; 129:260.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists. Induction of labor. ACOG practice bulletin #10. American College of Obstetricians and Gynecologists, Washington, DC 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/48\">",
"      Tukur J, Umar NI, Khan N, Musa D. Comparison of emergency caesarean section to misoprostol induction for the delivery of antepartum eclamptic patients: a pilot study. Niger J Med 2007; 16:364.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/49\">",
"      Seal SL, Ghosh D, Kamilya G, et al. Does route of delivery affect maternal and perinatal outcome in women with eclampsia? A randomized controlled pilot study. Am J Obstet Gynecol 2012; 206:484.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/50\">",
"      Alexander JM, Bloom SL, McIntire DD, Leveno KJ. Severe preeclampsia and the very low birth weight infant: is induction of labor harmful? Obstet Gynecol 1999; 93:485.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/51\">",
"      Nassar AH, Adra AM, Chakhtoura N, et al. Severe preeclampsia remote from term: labor induction or elective cesarean delivery? Am J Obstet Gynecol 1998; 179:1210.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/52\">",
"      Sibai BM, Spinnato JA, Watson DL, et al. Eclampsia. IV. Neurological findings and future outcome. Am J Obstet Gynecol 1985; 152:184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/53\">",
"      Okanloma KA, Moodley J. Neurological complications associated with the pre-eclampsia/eclampsia syndrome. Int J Gynaecol Obstet 2000; 71:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/54\">",
"      L&oacute;pez-Llera M. Main clinical types and subtypes of eclampsia. Am J Obstet Gynecol 1992; 166:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/55\">",
"      Conde-Agudelo A, Kafury-Goeta AC. Case-control study of risk factors for complicated eclampsia. Obstet Gynecol 1997; 90:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/56\">",
"      MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001; 97:533.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/57\">",
"      Moodley J. Maternal deaths due to hypertensive disorders in pregnancy: Saving Mothers report 2002-2004. Cardiovasc J Afr 2007; 18:358.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/58\">",
"      Sibai BM, Anderson GD, Abdella TN, et al. Eclampsia. III. Neonatal outcome, growth, and development. Am J Obstet Gynecol 1983; 146:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/59\">",
"      Chesley SC, Annitto JE, Cosgrove RA. The remote prognosis of eclamptic women. Sixth periodic report. Am J Obstet Gynecol 1976; 124:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/60\">",
"      Sibai BM, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986; 155:1011.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/61\">",
"      Gilstrap LC 3rd, Cunningham FG, Whalley PJ. Management of pregnancy-induced hypertension in the nulliparous patient remote from term. Semin Perinatol 1978; 2:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/62\">",
"      Sibai BM, Sarinoglu C, Mercer BM. Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis. Am J Obstet Gynecol 1992; 166:1757.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/63\">",
"      Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991; 165:1408.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/64\">",
"      Sibai BM, Ramadan MK, Chari RS, Friedman SA. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 1995; 172:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/65\">",
"      Aukes AM, de Groot JC, Aarnoudse JG, Zeeman GG. Brain lesions several years after eclampsia. Am J Obstet Gynecol 2009; 200:504.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/66\">",
"      M&ouml;ller B, Lindmark G. Eclampsia in Sweden, 1976-1980. Acta Obstet Gynecol Scand 1986; 65:307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/67\">",
"      Sibai BM, Abdella TN, Spinnato JA, Anderson GD. Eclampsia. V. The incidence of nonpreventable eclampsia. Am J Obstet Gynecol 1986; 154:581.",
"     </a>",
"    </li>",
"    <li>",
"     Campbell, DM, Templeton, AA. Is eclampsia preventable? In: Bonnar, J, MacGillivray, I, Symonds, ED (eds). Pregnancy Hypertension, University Park Press, Baltimore, 1980, p483.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?38/55/39801/abstract/69\">",
"      Bailly E, Savel J, Mahouy G, Jaureguiberry G. Plasmodium falciparum: isolation and characterization of a 55-kDa protease with a cathepsin D-like activity from P. falciparum. Exp Parasitol 1991; 72:278.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1662 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-B007036579-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39801=[""].join("\n");
var outline_f38_55_39801=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H27\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INCIDENCE AND EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Timing: antepartum, intrapartum, postpartum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOGENESIS OF SEIZURES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CLINICAL MANIFESTATIONS AND DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Maternal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Fetal",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      General principles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Treatment of hypertension",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Treatment of convulsions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Prevention of recurrent convulsions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Administration of magnesium sulfate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - Management of persistent convulsions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Delivery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      POSTPARTUM COURSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Maternal outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Perinatal outcome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Recurrence risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Long-term maternal prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Can eclampsia be predicted?",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Prevention of the first eclamptic seizure in preeclamptic women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Summary",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Recommendations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/1662\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/1662|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/18/12591\" title=\"figure 1\">",
"      Stroke mortality related to BP and age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/1662|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/60/43979\" title=\"table 1\">",
"      Criteria for severe preeclampsia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?43/39/44667\" title=\"table 2\">",
"      Risk factors for preeclampsia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?13/61/14300\" title=\"table 3\">",
"      Phases of tonic clonic seizures",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?21/50/22315\" title=\"table 4\">",
"      Eclampsia outcomes",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/56/24458?source=related_link\">",
"      Cerebrovascular disorders complicating pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/37/23129?source=related_link\">",
"      Clinical features and diagnosis of acute bacterial meningitis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/13/27863?source=related_link\">",
"      Clinical neurophysiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/3/25657?source=related_link\">",
"      Clinical presentation and diagnosis of brain tumors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/1/29721?source=related_link\">",
"      Diagnosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/57/37786?source=related_link\">",
"      Etiology, clinical manifestations, and diagnosis of vascular dementia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/9/25753?source=related_link\">",
"      Evaluation of the first seizure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/11/24761?source=related_link\">",
"      Gestational trophoblastic disease: Epidemiology, clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/39/44664?source=related_link\">",
"      Hypoglycemia in adults: Clinical manifestations, definition, and causes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/5/26714?source=related_link\">",
"      Inherited thrombophilias in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/27/41398?source=related_link\">",
"      Malignant hypertension and hypertensive encephalopathy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/7/13434?source=related_link\">",
"      Management of hypertension in pregnant and postpartum women",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/45/36567?source=related_link\">",
"      Management of myasthenia gravis in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/58/23464?source=related_link\">",
"      Manifestations of hyponatremia and hypernatremia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/49/43799?source=related_link\">",
"      Neuroprotective effects of in utero exposure to magnesium sulfate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/2/41000?source=related_link\">",
"      Obstetrical manifestations of the antiphospholipid syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/47/28410?source=related_link\">",
"      Overview of the evaluation of stroke",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/61/34777?source=related_link\">",
"      Pathogenesis of preeclampsia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?27/20/27978?source=related_link\">",
"      Preeclampsia: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/23/21882?source=related_link\">",
"      Preeclampsia: Management and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/40/41609?source=related_link\">",
"      Prevention of preeclampsia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/50/25386?source=related_link\">",
"      Primary angiitis of the central nervous system",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?30/37/31322?source=related_link\">",
"      Principles of labor induction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/16/43273?source=related_link\">",
"      Reversible posterior leukoencephalopathy syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/6/22633?source=related_link\">",
"      Risks associated with epilepsy and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?28/28/29130?source=related_link\">",
"      Spontaneous intracerebral hemorrhage: Pathogenesis, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/11/19642?source=related_link\">",
"      Status epilepticus in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/3/38968?source=related_link\">",
"      Viral encephalitis in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f38_55_39802="FL grade 2";
var content_f38_55_39802=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F85890%7EHEME%2F63064&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F85890%7EHEME%2F63064&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Follicular lymphoma, grade 2",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 378px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scattered throughout the centrocyte-like cells are five to 15 large, centroblast-like cells. Hematoxylin, phloxine, and saffron stain.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Ioachim HL, Medeiros LJ. Ioachim's Lymph Node Pathology, 4th ed, Lippincott Williams &amp; Wilkins, Philadelphia 2009. Copyright &copy; 2009 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Follicular lymphoma grade II (follicular mixed lymphoma)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 289px; height: 309px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    There is an intimate admixture of small cleaved cells (centrocytes) and large non-cleaved cells (centroblasts).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Warnke, RA, Weiss, LM, Chan, JK, Cleary, ML, Dorfman, RF. Tumors of the lymph nodes and spleen. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 14, 1995, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39802=[""].join("\n");
var outline_f38_55_39802=null;
var title_f38_55_39803="Differential diagnosis of memory loss";
var content_f38_55_39803=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F51421&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F51421&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of memory loss",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Symptom",
"      </td>",
"      <td class=\"subtitle1\">",
"       Usual cause",
"      </td>",
"      <td class=\"subtitle1\">",
"       Examples",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1_start\">",
"       Gradual onset of short-term memory loss and functional impairment in more than one domain:",
"      </td>",
"      <td class=\"sublist_other_start\" colspan=\"1\" rowspan=\"3\">",
"       Dementia",
"      </td>",
"      <td class=\"sublist_other_start\" colspan=\"1\" rowspan=\"3\">",
"       Alzheimer disease, Parkinson dementia, Lewy body dementia, Pick's disease, alcohol-related dementia, Creutzfeld-Jacobs disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       I. Executive function (finances, shopping, cooking, laundry, transportation)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"sublist1\">",
"       II. Basic activities of daily living (feeding, dressing, bathing, toileting, transfers)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Stepwise, sudden deterioration in cognition; episodes of confusion, aphasia, slurred speech, focal weakness",
"      </td>",
"      <td>",
"       Cerebrovascular disease",
"      </td>",
"      <td>",
"       Vascular dementia, multi-infarct dementia, Binswanger's dementia (subcortical dementia)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Acute cognitive impairment with clouded sensorium; difficulty with attention; may have hypersomnolence",
"      </td>",
"      <td>",
"       Delirium",
"      </td>",
"      <td>",
"       Hypo- or hyperglycemia, hypo- or hypernatremia, hypoxemia, anemia, intermittent cerebral ischemia, thyrotoxicosis, myxedema, alcohol withdrawal, sepsis, drugs (especially cholinergics, benzodiazepines, etc)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Complains of memory loss, decreased concentration, impaired judgment, feels worse in morning and hopeless",
"      </td>",
"      <td>",
"       Depression",
"      </td>",
"      <td>",
"       Minor depression, dysthymic disorder, major depression, pathologic grief reaction",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39803=[""].join("\n");
var outline_f38_55_39803=null;
var title_f38_55_39804="Urethral CA TNM men";
var content_f38_55_39804=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F50999&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F50999&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    TNM staging system for urethral cancer in men",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\">",
"       Primary tumor (T)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       TX",
"      </td>",
"      <td>",
"       Primary tumor cannot be assessed",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T0",
"      </td>",
"      <td>",
"       No evidence of primary tumor",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ta",
"      </td>",
"      <td>",
"       Noninvasive papillary, polypoid, or verrucous carcinoma",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tis",
"      </td>",
"      <td>",
"       Carcinoma in situ",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T1",
"      </td>",
"      <td>",
"       Tumor invades subepithelial connective tissue",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T2",
"      </td>",
"      <td>",
"       Tumor invades any of the following: corpus spongiosum, prostate, periurethral muscle",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T3",
"      </td>",
"      <td>",
"       Tumor invades any of the following: corpus cavernosum, beyond prostatic capsule, bladder neck",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       T4",
"      </td>",
"      <td>",
"       Tumor invades other adjacent organs",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle2_left\" colspan=\"2\">",
"       Urothelial (transitional cell) carcinoma of the prostate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Tis pu",
"      </td>",
"      <td>",
"       Carcinoma in situ, involvement of the prostatic urethra",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       Tis pd",
"      </td>",
"      <td>",
"       Carcinoma in situ, involvement of the prostatic ducts",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       T1",
"      </td>",
"      <td>",
"       Tumor invades urethral subepithelial connective tissue",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       T2",
"      </td>",
"      <td>",
"       Tumor invades any of the following: prostatic stroma, corpus spongiosum, periurethral muscle",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       T3",
"      </td>",
"      <td>",
"       Tumor invades any of the following: corpus cavernosum, beyond prostatic capsule, bladder neck (extraprostatic extension)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       T4",
"      </td>",
"      <td>",
"       Tumor invades other adjacent organs (invasion of the bladder)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\">",
"       Regional lymph nodes (N)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       NX",
"      </td>",
"      <td>",
"       Regional lymph nodes cannot be assessed",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N0",
"      </td>",
"      <td>",
"       No regional lymph node metastasis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N1",
"      </td>",
"      <td>",
"       Metastasis in a single lymph node 2 cm or less in greatest dimension",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       N2",
"      </td>",
"      <td>",
"       Metastasis in a single node more than 2 cm in greatest dimension, or in multiple nodes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\" colspan=\"2\">",
"       Distant metastasis (M)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       M0",
"      </td>",
"      <td>",
"       No distant metastasis",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       M1",
"      </td>",
"      <td>",
"       Distant metastasis",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Note: cTNM is the clinical classification, pTNM is the pathologic classification.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Used with the permission of the American Joint Committee on Cancer (AJCC), Chicago, Illinois. The original source for this material is the AJCC Cancer Staging Manual, Seventh Edition (2010) published by Springer New York, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39804=[""].join("\n");
var outline_f38_55_39804=null;
var title_f38_55_39805="FSH threshold";
var content_f38_55_39805=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F60133&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F60133&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    FSH threshold and follicular development",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 344px; height: 298px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The intercycle rise in serum FSH concentrations exceeds the threshold for recruitment of follicles for further development. The number of follicles recruited is determined by the time (\"window\") in which the serum FSH is above the threshold at which recruitment occurs.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39805=[""].join("\n");
var outline_f38_55_39805=null;
var title_f38_55_39806="RA of the elbow";
var content_f38_55_39806=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F76905&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F76905&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Rheumatoid arthritis of the elbow",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 258px; height: 287px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Lateral view of the elbow in a patient with rheumatoid arthritis (RA) reveals soft tissue swelling and osteopenia with destruction of the elbow joint (arrows). There are also secondary proliferative bony changes, which have arisen due to joint space destruction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Jonathan Kruskal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39806=[""].join("\n");
var outline_f38_55_39806=null;
var title_f38_55_39807="Pneumobilia due to gallstone ileus";
var content_f38_55_39807=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F68491&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F68491&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pneumobilia due to gallstone ileus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 307px; height: 391px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Plain film of the abdomen showing air in the intrahepatic biliary tree (arrows) and dilated loops of small bowel. Pneumobilia implies either a patent cystic duct or a fistula involving the common bile duct. The gallstone cannot be identified on this film. This is a common finding that is due to two factors: most stones are radiolucent; and gas or bony structures can obscure gallstones outside the biliary tree.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Nezam Afdhal, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f38_55_39807=[""].join("\n");
var outline_f38_55_39807=null;
